Table Of Content

VOLUME 54, JULY TO DECEMBER 1999 UROLOGY Pages Issue Pages Issue 1-200 July 583-772 October 201-384 August 173-944 November 385-582 September 945-1144 December 6A1—6A52 December Supplement AUTHOR INDEX Aarnink, R.G., 97 Barbaric, Z.L., Buell, U., 900 Christiano, A.P., 86, 162 Abrahamsson, P.-A., 329 Barrett, D.M.., Bukowski, R.M., 617 Chung. T:, 573 Abrams, P., 278 Barthold, J.S., Bukowski, T.P., 1093 Civantos, F., 533, 682 Acar, O:,553 Basharkhah, A., 18, 73, 603 Bull, C.A., 124 Clayman, R.V., 366, 437, Adam, R.M., 523 Bauerfeind, P., 553 Burgers, J.K., 1058 590, 744, 767 Adami, H.-O., 284 Becich, M.J., 171 Burnett, A.L., 392, 580 Cochran, S.T., 919 Adams, K., 124 Becks U.P, 973 Burno, D.K., 162 Collins, D.R., 162 Adams, M.C., 724 Beerlage, H.P., 97, 273 Burns, M., 162 Colombeau, P., 744 Addicks, K., 416 Benedetti, G., 629 Bursa, B., 18, 73, 603, 846 Comiter, C.V., 454, 819, 1085 Agarwal, A., 308, 894 Bengtsson, E., 862, 1028 Busch, C., 862, 1028 Condie, J.D., Jr, 1012 Ahlgren, G., 329 Benson, M.C., 490, 852 Butler, R., 561 Connell, P.P., 875 Akakura, K., 313 Benton, J.B., 968 Connolly, S., 162 Akgiin, Y., 972 Bercowsky, E., 366, 437 Cooney, K.A., 607 Akimoto, S., 313 Bergman, J., 1003 Cooper, C.S., 162 Akino, H., 763 Bergner, D., 662 Cadeddu, J.A., 909 Coquet, A., 194 Albani, J., 869 Bergstralh, E.J., 105, 479 Cain, M.P., 724, 923 Corcos, J., 815 Albers, P., 714 Berman, J.R., 385, 578 Candas, B., 194 Corica, A., 67 Albertsen, P., 301 Berman, L., 385 Canning, D.A., 162 Corica, F.A., 67 Albertsen, P.C., 567 Berry, M.P., 124 Cannon, A., 278 Corn, B.W., 495 Alcini, A., 629 Cappelleri, J.C., 346 Cornel, E.B., 366 Alcini, E., 629 Bertrand, P.E., 808 Capristo, E., 629 Coulange, C., 857 Ali, A., 612 Bex, A., 458 Carducci, M.A., 745 Crawford, E.D., 6A-1, 6A-51 Beyer, D.C., 880 Cremerius, U., 900 Altmannsberger, M., 988 Carr, M., 366 Bhargava, V., 689 Crisci, A., 923 Al-Uzri, A., 1097 Carroll, P.R., 1049 Bierhoff, E., 714 Critz, F.A., 968 Ambuthl, P.M., 55 3 Cartei, G., 923 Bilancioni, E., 367 Cromie, W.J., 917 Amling, C.L., 924 Carter, H.B., 291, 780 Billings, EJ., 163 Cummings, G.D., 1044 An, G., 1105 Casale, A.J., 724 Bishoff, J.T., 1064 Cutherell, L., 1012 Andersen, J.T., 278 Case, D., 853 Blander, D.S., 719 Andriole, G.L., 194 Castellan, M.A., 152 Bloch, W., 416 Ang, P.C.S., 363 Catalona, W.J., 220, 839 Bloom, D.A., 767 Angeli, A., 612 Cathomas, G., 553 Blute, M., 479 D’Addessi, A., 629 Angelopoulou, K., 753 Cespedes, R.D., 198, 548, 597 Blute, M.L., 105 Dadds, L., 834 Angermeier, K.W., 352 Chaikin, D.C., 806 Bogers, H.A., 97 D’Amico, A.V., 201 Antony, S.J., 952 Chan, D.W., 4, 220, 839 Bologna, R.A., 982 Darouiche, R.O., 976 Aoki, Y., 225 Chan, D.Y., 1088 Bolton, S., 325 Darras, F.S., 162 Arai, Y., 44, 22 Me 3 |e: Boone, T., 466 Chancellor, M.B., 636, 929 Darte, C., 839 Arakawa, S., 56 Chang,J. , 164 Boone, T.B., 976 David, M.P., 268 Arcadi, J.A., 18 Chang, S.-Y., 377 Anikan, N., 157, 905 BBoorrcbhoerrosg,l u,H. , P.9G0.0, 924, 1097 Charles, L.G., 1112 DDaayy,, KM..CL..,, 774466 Atala, A., 407 Chatelain, C., 473 De Antoni, P., 923 Atan, A., 636 Borchert, G., 753 Chaussy, C., 273 Debruyne, F.MJ., 97, 273 Atkinson, G., 1098 Bostwick, D.G., 67, 479 Cheah, F-K., 363 de Gier, R.P.E., 366 Aus, G., 329 Bourg, S., 744 Chekmareva, M.A., 162 DeHaven, J.I., 56 Autet, W., 473 Boyle, P., 662 Chen, F., 407 Delaere, K.P.J., 561 Awan, A., 700 Brabbins, D.S., 111 Chen, M.-H., 700 de la Rosette, J.J.M.C.H., 97, Bracken, R.B., 662, 670 Chen, R.N., 1064 23 Brackman, F., 473 Cheng, L., 67 de la Taille, A., 1039 Brame, M., 1097 Chiaccherini, R.P Destefanis, P., 612 Babaian, R.J., 976 Brandt, J.M., 787 Chiba, K., 1078 DeWolf, W.C., 163 Bach, M.A., 278 Brawer, M.K., 2 Chin, N.W., 744 Dhabuwala, C.B., 145, 925, 976 Badalament, R.A., 135, 295 Brendler, C.B., 162, 940 Chinn, D.O., 135 Diamandis, E.P., 753, 941 Bagiella, E., 490, 1039 Bright, S.P., 1105 Chmiura:SJ., 573 Dilger, J.A., 130 Bagolan, P., 367 Broberg, J., 853 Cho, J.S., 164 Diokno, A.C., 450 Bahn, D.K., 135, 295 Broderick, G.A., 719 Choe, J.M., 641 Ditropan XL Study Group, 420 Bahn, J.M., 295 Bruce, R.G., 647 Chow, G.K., 999 Djavan, B., 18, 73, 517, 603, Balcom, A.H., 366 Bruch, H.-P., 964 Chow, N.-H., 561 846 Bales, G.T., 86 Bruskewitz, R., 278, 670 Ghrisp; G:E., 1142 Dmochowski, R.R., 43 © 1999, ELsevieR SCIt NCE INC. 0090-4295/99/$20.00 1130 ALL RIGHTS RESERVED PIL SOO090-4295(99)00524-5 VOLUME 54, JULY TO DECEMBER 1999 UROLOGY Pages Issue Pages Issue 1-200 July 583-772 October 201-384 August 173-944 November 385-582 September 945-1144 December 6A1—6A52 December Supplement AUTHOR INDEX Aarnink, R.G., 97 Barbaric, Z.L., Buell, U., 900 Christiano, A.P., 86, 162 Abrahamsson, P.-A., 329 Barrett, D.M.., Bukowski, R.M., 617 Chung. T:, 573 Abrams, P., 278 Barthold, J.S., Bukowski, T.P., 1093 Civantos, F., 533, 682 Acar, O:,553 Basharkhah, A., 18, 73, 603 Bull, C.A., 124 Clayman, R.V., 366, 437, Adam, R.M., 523 Bauerfeind, P., 553 Burgers, J.K., 1058 590, 744, 767 Adami, H.-O., 284 Becich, M.J., 171 Burnett, A.L., 392, 580 Cochran, S.T., 919 Adams, K., 124 Becks U.P, 973 Burno, D.K., 162 Collins, D.R., 162 Adams, M.C., 724 Beerlage, H.P., 97, 273 Burns, M., 162 Colombeau, P., 744 Addicks, K., 416 Benedetti, G., 629 Bursa, B., 18, 73, 603, 846 Comiter, C.V., 454, 819, 1085 Agarwal, A., 308, 894 Bengtsson, E., 862, 1028 Busch, C., 862, 1028 Condie, J.D., Jr, 1012 Ahlgren, G., 329 Benson, M.C., 490, 852 Butler, R., 561 Connell, P.P., 875 Akakura, K., 313 Benton, J.B., 968 Connolly, S., 162 Akgiin, Y., 972 Bercowsky, E., 366, 437 Cooney, K.A., 607 Akimoto, S., 313 Bergman, J., 1003 Cooper, C.S., 162 Akino, H., 763 Bergner, D., 662 Cadeddu, J.A., 909 Coquet, A., 194 Albani, J., 869 Bergstralh, E.J., 105, 479 Cain, M.P., 724, 923 Corcos, J., 815 Albers, P., 714 Berman, J.R., 385, 578 Candas, B., 194 Corica, A., 67 Albertsen, P., 301 Berman, L., 385 Canning, D.A., 162 Corica, F.A., 67 Albertsen, P.C., 567 Berry, M.P., 124 Cannon, A., 278 Corn, B.W., 495 Alcini, A., 629 Cappelleri, J.C., 346 Cornel, E.B., 366 Alcini, E., 629 Bertrand, P.E., 808 Capristo, E., 629 Coulange, C., 857 Ali, A., 612 Bex, A., 458 Carducci, M.A., 745 Crawford, E.D., 6A-1, 6A-51 Beyer, D.C., 880 Cremerius, U., 900 Altmannsberger, M., 988 Carr, M., 366 Bhargava, V., 689 Crisci, A., 923 Al-Uzri, A., 1097 Carroll, P.R., 1049 Bierhoff, E., 714 Critz, F.A., 968 Ambuthl, P.M., 55 3 Cartei, G., 923 Bilancioni, E., 367 Cromie, W.J., 917 Amling, C.L., 924 Carter, H.B., 291, 780 Billings, EJ., 163 Cummings, G.D., 1044 An, G., 1105 Casale, A.J., 724 Bishoff, J.T., 1064 Cutherell, L., 1012 Andersen, J.T., 278 Case, D., 853 Blander, D.S., 719 Andriole, G.L., 194 Castellan, M.A., 152 Bloch, W., 416 Ang, P.C.S., 363 Catalona, W.J., 220, 839 Bloom, D.A., 767 Angeli, A., 612 Cathomas, G., 553 Blute, M., 479 D’Addessi, A., 629 Angelopoulou, K., 753 Cespedes, R.D., 198, 548, 597 Blute, M.L., 105 Dadds, L., 834 Angermeier, K.W., 352 Chaikin, D.C., 806 Bogers, H.A., 97 D’Amico, A.V., 201 Antony, S.J., 952 Chan, D.W., 4, 220, 839 Bologna, R.A., 982 Darouiche, R.O., 976 Aoki, Y., 225 Chan, D.Y., 1088 Bolton, S., 325 Darras, F.S., 162 Arai, Y., 44, 22 Me 3 |e: Boone, T., 466 Chancellor, M.B., 636, 929 Darte, C., 839 Arakawa, S., 56 Chang,J. , 164 Boone, T.B., 976 David, M.P., 268 Arcadi, J.A., 18 Chang, S.-Y., 377 Anikan, N., 157, 905 BBoorrcbhoerrosg,l u,H. , P.9G0.0, 924, 1097 Charles, L.G., 1112 DDaayy,, KM..CL..,, 774466 Atala, A., 407 Chatelain, C., 473 De Antoni, P., 923 Atan, A., 636 Borchert, G., 753 Chaussy, C., 273 Debruyne, F.MJ., 97, 273 Atkinson, G., 1098 Bostwick, D.G., 67, 479 Cheah, F-K., 363 de Gier, R.P.E., 366 Aus, G., 329 Bourg, S., 744 Chekmareva, M.A., 162 DeHaven, J.I., 56 Autet, W., 473 Boyle, P., 662 Chen, F., 407 Delaere, K.P.J., 561 Awan, A., 700 Brabbins, D.S., 111 Chen, M.-H., 700 de la Rosette, J.J.M.C.H., 97, Bracken, R.B., 662, 670 Chen, R.N., 1064 23 Brackman, F., 473 Cheng, L., 67 de la Taille, A., 1039 Brame, M., 1097 Chiaccherini, R.P Destefanis, P., 612 Babaian, R.J., 976 Brandt, J.M., 787 Chiba, K., 1078 DeWolf, W.C., 163 Bach, M.A., 278 Brawer, M.K., 2 Chin, N.W., 744 Dhabuwala, C.B., 145, 925, 976 Badalament, R.A., 135, 295 Brendler, C.B., 162, 940 Chinn, D.O., 135 Diamandis, E.P., 753, 941 Bagiella, E., 490, 1039 Bright, S.P., 1105 Chmiura:SJ., 573 Dilger, J.A., 130 Bagolan, P., 367 Broberg, J., 853 Cho, J.S., 164 Diokno, A.C., 450 Bahn, D.K., 135, 295 Broderick, G.A., 719 Choe, J.M., 641 Ditropan XL Study Group, 420 Bahn, J.M., 295 Bruce, R.G., 647 Chow, G.K., 999 Djavan, B., 18, 73, 517, 603, Balcom, A.H., 366 Bruch, H.-P., 964 Chow, N.-H., 561 846 Bales, G.T., 86 Bruskewitz, R., 278, 670 Ghrisp; G:E., 1142 Dmochowski, R.R., 43 © 1999, ELsevieR SCIt NCE INC. 0090-4295/99/$20.00 1130 ALL RIGHTS RESERVED PIL SOO090-4295(99)00524-5 Docimo, S.G., 358, 561, 727, Freedman, A.L., 359 Grob, B.M., 744 Irwin, R.J., Jr., 234 909 Freedman, G.M., 118 Grocela, LA, 375 Isaka, S., 313 Doebler, R.W., 366 Freeman, M.R., 523 Gross, M., 607 Ishikawa, N., 652 Domen, R.E., 130 Freese, R., 988 Grossfeld, G.D., 1049 Israeli, R.S., 208 Donehower, R.C., 1064 Fried, M., 553 Groutz, A., 268 Issa, M.M., 625, 923 Dotan, Z.A., 744 Frimmel, H., 862 Gruppo Piemontese Ito, H., 313 Douno, S., 829 Frischer, J., 1082 Incidentalomi Surrenalici, Iwaki,H ., 141 Drouin, J., 808 Fe %.235 612 Dukes, K.A., 424 Furr, B.J.A., 194 Gudziak, M.R., 1008 Dumas, J.P., 744 Fusilier, H.A., 670 Gunther, R.W., 900 Jacobs, G., 416 Dunbar, J.C., 925 Fussner, A.L., 23 Jacobsen, C.A., Duque, J.L.F., 523, 796 Jacobsen, > Ee. 3 Dutta, T.C., 891 Haas, C.A., 559 jaffa, A., 268 Dversdall, B.C., 23 Hachiya, T., 313 Jaffe, C.A., 607 Gal, A.A., 561 Hafez, K., 994 Jaffee, E.M., 623 Galloway, N.T.M., 647 Hahnfeld, L.E., 162 Jakse,G ., 900 Game, X., 923 Hald, T., 278 Jani. A.B., 700 Eastham, J.A., 709, 869, 1035 Garnick, M.B., 323 Hall, S.J., 1098 janitzky, V., 433 Gasser, T.C., 539 Eble, J.N., 561 Hallak, J., 894 Janulis, L., 164 Egevad, L., 862, 1028 Gatti, C., 367 Hamaguchi, A., 44 Jarow, J.P., 942 Eghazarian, C., 857 Gazi, M.A., 162 Han, K.-r., 162 Jasti, B.R., 6A-22 Ehrén, I., 264 Gearhart, J.P., 726 Handa, V.L., 923 Jerkins, G.R., 356 Eid, J.F., 891 Gee, J., 730 Hanks, G.E., 118, 178 Jhaveri, F.M., 884 Geisinger, M.A., 999 EFisenberger, M.A., 745 Hanlon, A.L., 178 Jiang, Y., 925 Gennaro, M.D., 367 Elbahnasy, A.M., 366, 437 Hanna, H., 976 John, H., 539 El-Galley, R., 625 Gerber, G.S., 86, 557 Hanna, M.K., 383 Johnson, D.B., 561 El-Galley, R.E.S., 647 Gershbaum, M.D., 34 Hara, I., 562 Johnson, E.L., 670 Elia, G., 1003 Gettman, M.T., 479 Hara, S., 562 Jones, K.A., 791 Emoto, A., 829 Getzenberg, R.H., 171 Harkaway, R.C., 366 Jordan, M., 366 Eng, M.H., 1112 Ghavamian, R., 105 Harmon, J].D., 366 Joseph, D.B., 362 Ghawidel, K., 18, 73, 846 Engel, J.D., 164 Hauri, D., 539, 553 Engelmann, U., 416 Gheiler, E.L., 1008 Hedican, S.P., 727 Ennis, R.D., 490 Giessing, M., 940 Hedlund, H., 278 Kaci, G., 539 Epstein, J.I., 291, 528, 791, 934 Gilchrist, B.F., 1082 Heesakkers, J.P.F.A., 561 Kakizoe, T., 313 Erden, I., 157 Gill, I.S., 215, 734 Hemal, A.K., 590 Kalble, T., 458 Ersay, A., 972 Ginsberg, P.C., 366 Hennenfent,M ., 229 Kalish, J., 923 Ertl, C.W., 162 Giorlandino, C., 367 Henning, J.M., 424, 503 Kalish, L.A., 1022 Esenler, A.C., 41] Girman, C.]., 335, 670 Herndon, C.D.A., 1097 Kamat, A.M., 56 Eskew, L.A., 853 Gittelman, M., 662 Herrero, E., 656 Kamidono, S., 562 Esposito, M., 234 Gleason, D.M., 420 Herulf, M., 264 Kamradt, J.M., 746 Gleave, M.E., 6A-36 Kanamaru, H., 763 Hickey, D.P., 923 Goégus, O., 157, 905 Kanba, T., 44 Hinkle, G.H., 1058 Goldfarb, D.A., 923 Kane, C.]., 744 Hinman, J., 1044 Fabozzi, S., 194 Goldie, J., 6A-36 Kantolf, P.W., 523, 1064 Hoenig, D.M., 590 Fabrizio, M.D., 442 Goldstein, I., 385, 578, 587 Kantor, $.D., 670 Holladay, C.T., 968 Faerber, G.J., 607 Goll, A., 714 Kaplan, S.A., 578, 776 Holladay, D.A., 968 Fanasca, A., 629 Gonzalez, J.A., 111 Kaplan, S.H., 424 Homsy, Y., 1097 Feitz, W.F.J., 366 Gonzalez, R., 359 Kapoor, A., 923 Honda, M., 1078 Fergany, A.F., 352 Goodwin, S., 164 Kardar, A.H., 193 Horan, P., 183 Ferguson, S., 23 Gordon, D., 268 Karpman, E., +11 Hosseini, A., 264 Ferrer, F.A., 567, 1097 Gordon, D.A., 982 Kasagi, Y., 829 "HrubyS,. . 18, 73, 846 Filbeck, T., 247 Gosalbez, R., Jr, 152 Kattan, M.W _ 709. 869 Hsieh, C.-C., 284, 823 Finasteride Urodynamics Goujon, J.-M., 467 Katz, A., 1039 Hsu, C.X., 1112 Study Group, 278 Gousse, A.E., 454 Kavoussi, L.R., 1064 Huang, A., 561 Finlay, J.A., 220, 839 Grado, G.L., 204 Kay, R., 994 Huang, C.-H., 823 Fiori, C., 612 Graham, S.D., Jr, 561 Kazimoglu, H., 50 Huang, J.-K., 823 Firlit, C.F., 383 Grainger, R., 162 Keating, M.A., 724 Hubert, J., +67 Fischer, C., 988 Gralnek, D., 1097 Kedia, A.W., 583 Hudes, G R., 118 Fishbain, D.A., 579 Grasso, M., 240 Kedia, S., 308, 583 Hugosson, J., 329 Flanders, S.C., 424, 503 Gravlin, K., 607 Kestin, L.L., 111 Hurle, R., 258 Flechner, $.M., 923 Gray, C.L., 744, 1097 Khair, A.A., 67 Hussain, M., 6A-22 Fleming, P., 359 Gray, T., 662 Khoury, A.E., 160 Fontana, D., 612 Greenberg, N.M., 1112 Kiel, H.J., 247 Forman, J.D., 325 Greenberger, M., 365 Kim, H., 295 Foster, B., 37 Greene, C., 135 Iczkowski, K.A., 67 Kim, H.L., 557 Fournier, C., 815 Greenfield, S., 424 Ignacio, L., 700, 875 Kim, S.-C., 148 Fowler, J., 670 Greenstein, A., 430 Induhara, R., 744 Kim, S.-]., 164 Fowler, J.E., Jr, 1017 Grignon, D., 1044 International Prostatitis Kim, S.W., 544 Fraiman, M., 240 Grmoljez, P., 679 Collaborative, 229 Kin, S., 44 Fraimow, H.D., 982 Groat, W.C., 929 Irani, J., 467 Kinsman, S., 561 UROLOGY 54 (6), 1999 Kirkali, Z., 50 Lee, N., 490 Mayo, M.E., 252 Nickel, J.C., 229 Kirkels, W.J., 718 Leé, Y-H..823 McBride, R.B., 875 Nickerson, T., 1120 Kirsh, E.J., 86, 573 Lehmann, K., 539 McCammon, K.A., 509 Niggemann, S., 416 Kitahara, S., 1078 Leibovitch, I., 193 McCullough, D., 853 Noe, H.N., 356 Klee, G.G., 839 Lemack, G.E., 37, 461 McDougal, E., 767 Noll, F., 458 Klee, L.W., 679 Lembo, A., 258 McDougal, W.S., 373 Nomura, Y., 829 Klein, E.A., 130, 366, 617, 884 Lemkin, P.F., 934 McDougall, E.M., 437 Norbut, A.M., 366 Klionsky, D., 135 Leng, W.W., 597 McGuire, E.J., 597 Nordling, J., 278 Klotz, D.H., 1082 Lemer,’S.P. 561 McKenna, P.H., 1097 Noriki, S., 763 Klotz, L., 956 Lessing, J.B., 268 McKinlay, J.B., 1022 Novick, A.C., 215, 617, 994, Klotz, T., 416 Levin, R.M., 183 McNamara, D.E., 625 1091 Klutke, C.G., 1003 Levin, S.S., 183 Megias,J. , 656 Nudell, D.M., 1049 Klutke, J.J., 1003 Levine, M., 240 Meka, C.S.R., 1105 Nyberg, L.M., 229 Kolettis, P.N., 894 Levinson, A.K., 968 Melegos, D.N., 753 Kolligian, M.E., 383 Levitt, S.B., 561 Melman, A., 662 Kolm, P., 509 i a 2453025 Mian, A., 1012 Obek, C., 533, 682 Kolon, T.F., 1097 Li, W., 829 Miayake, H., 6A-36 Oefelein, M.G., 694 Kolski, J.M., 1017 Lianidou, E., 753 Miller, J., 988 Offiah, L., 162 Kolvenbag, G.J.C.M., 194 Libertino, J.A., 1058 Miller, L.J., 567 Oh, W.K., 1064 Konami, T., 44 Lieber, M.M., 335 Miller, M.C., 791 O'Hara, J.F., jr; 130 Konety, B.R., 171, 636 Lilja, H., 753 Miller, P., 278 Ohashi, Y., 313 Koo, J., 744 Lin, D.W., 366 Milliron, A.R., 23 Ohnishi, N., 183 Kotake, T., 313 Lindquist, R., 567 Mimata, H., 829 Okabe, T., 44 Kovar, D.A., 573 Littrup, P.J., 1044 Mingrone, G., 629 Okada, K., 313, 763 Kowalczyk, P., 567 Litwin, M.S., 503 Mira, A., 656 Okada, T., 225 Koyle, M.A., 912 Lopez-Po, P., 952 Mishra, A., 346 Okada, Y., 44 Kozlowski, D., 670 Losa, A., 258 Miwa, Y., 763 Okubo, K., 44, 225 Kratzik, C.,517 Loughlin, K.R., 523, 796 Miyake, H., 562 Olencki, T.E., 617 Krege, S., 458 Low, L.L.M., 363 Molberg, K., 162 Olsen, J.O., 1058 Kreutzer, D.L., 567 Lowe, F.C., 81 Montague, D.K., 352, 384 Olson, P.J., 81 Kreutzer, E.R., 34 Lu, C.-M., 823 Monti, P.R., 152 Olsson, C.A., 490, 1039 Krieger, J.N., 366 Lubeck, D.P., 424, 503 Montie, J.E., 319 O'Malley, K.J., 923 Krill, D., 171 LuecEF:, 739 Moon, T.D., 162 Onik, G.M., 135 Krongrad, A., 949 Lummen, G., 458 Mootha, R.K., 561 Ornstein, D.K., 194 Kubricht, W.S., III, 1035 Lundberg, J.O.N., 264 Mor, Y., 744 Ortega, J.-C., 857 Kumamoto, Y., 335 Lundberg, S., 329 Mori, H., 829 Orth, K., 746 Kumar, A., 295 Lu-Yao, G.L., 301 Moro, U., 923 Osella, G., 612 Kumar, A.B., 135 Morton, R.A., Jr, 869 Osterloh, I.H., 346 Kumar, S., 796 Mottet, N., 467 O'Toole, K.M., 1039 Kundu, S.D., 164 Ma. C.-P.. 377 Moyad, M.A., 319 Otto, T., 458 Kuo, H.-C., 90, 802 Maeda, H., 22 Mroczek-Musulman, E., 744 Oyama, N., 763 Kupelian, P.A., 884 Maekawa, S., Miller, S.C., 714 OzeroE., 30 Kursh, E.D., 617 Munding, M., 1097 Maguire, R.T., 1058 Kusne, S., 366 Mungan, M.U., 50 Main, B., 509 Munoz, D.R., 420 Maisonnette, F., 744 Pacelli, A., 67, 479 Munson, J.L., 730 Malavaud, B., 923 Padley, R.J., 81 Murphy, D.M., 923 Labbie, A., 152 Malice, M.-P., 278 Paick, J.-S., 544 Murphy, G.P., 6A-19 Lablanc, G., 194 Malik, S.N., 62 Palmer, J.S., 162 Murphy, W.M., 62 Labrie, F., 194 Malyszko, B., 490 Palmer, L.S., 34, 561 Mustonen, S., 278 Lagiou, P., 284 Mangold, L.A., 791 Pannek, J., 934 ahaie, M., 607 Manibo, J.F., 742 Panser, L.A., 335 ai, S., 533, 682, 949 Manyak, MJ., 1058 Pantuck, A., 208 _akin, M.M., 308 Manzarbeita, C., 366 Nachmann, M.M., 366 Pantuck, A.J., 162 _akshmanan, Y., 934 Manzetti, A., 258 Nakada, S.Y., 162 Panvichian, R., 746 _amm, D.L., 56 Marberger, M., 18, 73, 517, Nangia, A., 636 Parchment, R.E., 6A-22 an, S.-J., 823 603, 846 Nap, M., 561 Park, C-H., 252 ang, E.K., 234 Marinbakh, A.Y., 744 Naughton, C.K., 744 Partin, A.W., 1, 220, 791, ang, S., 164 Marshall, F.F., 913, 1088 Neal, C.E., 1058 839, 934, 1058 ange, P.H., 252, 6A-1 Marshall, V.R., 834 Negendank, W.G., 118 Pasqualotto, F., 583 -angenstroer, P., 23 Martinez, A.A., 111 Nehra, A., 587 Pasta, D.J., 503 arson, T.R., 67 Masel, J., 1097 Nelson, C., 6A-36 Pathologist Multi Center Masoudi, J.F., 744 Nelson, D.R., 308 Study Group, 467 audone, V.P., 567 Masumori, N., 335 Nelson, J.B., 1064 Paulhac, P., 744 Laufer, M., 745 Mateo, R., 366 Netto, J.M.B., 742, 744 Pearson, J.D., 780 Lechevallier, E., 857 Matos-Ferriera, A., 278 Newhouse, J.H., 490 Pedersen, K., 329 Lecksell, K., 291, 528 Mattson, S., 862 Newman, J., 559 Pels Rijcken, T.H., 1068 Lee, C., 164 Matzkin, H., 430 Newman, J.L., 561 Peretsman, S.J., 548 Lee F., 135; 295 Maxa, L.S., 968 Nezu, F.M., 929 Pérez, L.M., 742, 744 Lee, K.L., 444 May, R., 709 Ng, C.S., 366 Perrotti, M., 208 1132 UROLOGY 54 (6), 1999 Peters, K.M., 450 Rosenbaum, R.R., 34 Shinohara, K., 689 Thuroff, S., 273 Petros, J.A., 923 Rosenblum, M., 6A-1] Shoskes, D.A., 960 Tigrani, V.S.. 689 Petrylak, D.P., 490, 6A-30 Ross, B.D., 1112 Shown, T., 662 Tiguert, R., 1008 Peyrat, L., 467 Rosser, C.J., 853 Shrake, P.D., 968 Tindall, D.J., 839 Piantadosi, S., 1058 Roux, F., 857 Shu, S., 617 lobisu. K.-I.. 313 Pichlmeier, U., 247 Rovner, E.S., 744 Sidransky, D., 561 Tolcher. A.. 6A-36 Pa ickens, C.L., 223 . Roxby, D., 8232 4 SieCgeel , R2 ., 162 ) Townsend, M.F., Ill, =5 61 bdiee een > M.R.> , 132¢ Rubben" , EL; 45SQ8 Silveorr, BRD. L., ~5 61 [richopoulos, :D ., 284 I ienkny, A., 617 ag Rubin, M.A., 1039 Silveri, M., 367 lrichopoulou, A., 284 Pienta, K.J., 319, 746, 1112 Rubinowicz, D., 682 Simard, J., 194 ricoli, J.V., 178 CU 9 9 aS Piille at, MJ., 7744 6 : RRuussso, so, PP.., , 22 8 Siimm mons, G.R., 727 24 riest, J.A., 1008 Pilepich, M.V., 495 Simons, J.W., 401 : . ieckava B14 Se Tsukamoto, | Pinckard, P., 1035 Sinibaldi, V.J., 745 Tu. LM. 982 é o ee u,L -5 JOL Pinnock, C.B., 834 Sadek. S.. 533. 682 Skoog, S.J., 365 I B50 . , 79 Sadek, S., 533, 682 “ee Sens una, B., 5¢ Pinover, W.H., 178 ‘ mr “a ' : 162 Slezak, J., 105, 479 CD vied SY agalowsky, A.1., 162 te: urner, Pinto, K., 356 PS os 167 Smith, J.A., Jr, 976, 6A-8 viens ; = Saint, F., 46 ae Turner, S.L., 124 Pircon, R., 366 < ‘ va Smith, J.J., 11, 730 ; aito, S., 1- as Plante, M.K., 411 Cal ; 1. 940 Smith, M.D., 346 %2 = alomon, L., é Plautz, G.E., 617 < ; Catt M. 65¢ Snodgrass, W.T., 6 ne ‘ anchez-Carbayo, M., 656 707 PLESS Study Group, 662, 670 S 1 + O aoe RE. 719 Snow, P.B., 787 Polansky, M., 982 pn oe "ea BH Soeregi, G., 603 dupa, D., 366 1 + and, F.K., 42 . = > . Polascik, T.J., 382 3 Solliday, M.P., 744 ehling, D.T., 561 5 Wak: 5 Sanda, M.G., 1112 see ae rich. T.. 247 Pollak, M., 1120 taal K. 617 Soloway, M.S., 533, 682, irich, oti Poole. E.C.. 23 sandstrom, K., sé 6A-8 padhyay, J., 359, 964, 1044 Ce aes Santis, W.F., 163 : - - te 14 Porpiglia, F., 612 < ci RA. 252 Soria, F., 656 sami, M., 313 Portis, A., 437 ae a 7 —_ Soygtr, T., 157, 905 zzo, R.G., 994 eons : arda, R., 56 : reas Potter, S.R., 528, 791, 913 C nsec j.-P., 923 Spina, V., 367 ; arramon, J.-P., 92 ae Pound, C.R., 934 ‘ ns 709 ; Spirnak, J.P., 559 : : cs artor, O., Presti, J.C., Jr., 689, 6A-47 . ; ; Sprung, J., 130 <s ia sas Satoh, F., 829 ProstaScint Study Group, 1058 : ; Stadler, W.M., 373 idz 700 Scantlebury, V., 366 Staskin. D.R. 641 aida, F., 7( Puri, K., 1008 Scardino. P.T.. 561. 976 ASR, U-K., aishampayan, U., 6A-22 st Steers, W.D., 12 lerie. E.. 1082 SSccc]hh aafnenre,, WFF..I,J. . , 27186 1262 SteinerG,. , s5 61 = aallaencie n,a y G.,m eres—7 7 3 = Steiner, M.S., 942, 976 ee VAR Raad, I.1., 976 Schellhammer, P., 194 Steinert. B.W.. 450 an Andel, G., 1068 = einert, B.VV., 2H - > 744 Raasch, J., 1044 Schellhammer, P.F., 509 Stier DM. 424 an Arsdalen, K., 744 1 * a : ; es aaa Stier, D.M., 42 i cr 2 Rabbani, F., 28, 208 Schick, E., 808 BS. an Die, C.E., 366 : Stoddard, M.L., 503 oo ae ee eta Racioppi, M., 629 Schiff, P.B., 490 Sinkioe Waa. 446 an Haarst, E.P., 1068 . -_ - oe a 4 > y= Ragni, E., 467 Schlatmann, T.J.M., 1068 Stone. A.. 923 asavada, S.P., 454, 819, 1085 = F one, 5 oe 2)< Rahmanou, F., 744 Schmitz, F.J., 23 Stoner, ].. 171 elasco, J ae 7 . - 3 UL 4 # f Rajfer, J., 919, 960 Schnell, F.J., Jr, 968 ‘ eltri, R.W., 791, 1105 Rajpurkar, A., 145=, 925‘ Schoenberg,5 M., e5 61 StopPpIa cher, R., +11] 7 1] 1] # Streem, S.B., 999 sp nggeivieingdre Ramenofsky, M.L., 1082 Schoeneich, G., 714 Strombere. 1.S., 111 iele, M.K., 444 Pa = . tromberg, j.5., iti Ramon, J., 744 Schubert, J., 433 Strum. S.B.. 324 ijayakumar, S ° - . de an on i > = Rassweiler, J.J., 734 Schulam, P.G., 580, 727 Suda. S.. 652 Villers, A., 923 ne sect aie ae da, - ie Raysor, S.L., 178 Schulman, C.C., 382, 517, 846 Sullivan. M.. 670 Virag, R.. 1073 : = > oe . ee 11Vé , O¢ Raz, S., 454, 819, 1085 Schwartz, B.F., 444 Semsiensh’ ¥. 333 Vivas. C.. 366 : se osnl, , Recker, F., 458 Scott, C.A., 923 277 : a s Sun, G.-H., 377 Reichelt, O., 433 Scriven R, 1082 Susset: 1. 420 A 4: + ) ‘7 - SSetl, . ys Remzi, M., 517, 603, 846 Sedelaar, J.P.M., 97 Suthoclanad ES eriand, KR.S., Ren> froey,e. DD. L., 1+0 1177 Seeggza ll, S.. S., ¢6 2a5 n ; Senki ¥. e7e6e3 aldstreicher, J., 662, 67- 0 Rhandawa, P., Seitz, C., 18, 517, 603 alsh, J.B., 162) Rhodes, T., Sekhon, V.S., 894 Walsh, PJ., 921 Richie, J.P., 6A-15 SelcukiM,. , 157 ae ang, D., 662 Richter, F., 234 Selli, C., 923 Taconis, W.K., 1068 ang, D.Z., 670 Riden, D., 1097 Seo, K.K., 148 Tammela, T.L.J., 278 arren, J., 30] Rigby, O.F., 670 Shaer, A.H., 118 Tanagho, E.A., 1007 atkins-Bruner,D ., 178 Rink, R.C., 724, 923 Shafik, A., 368 Taylor, A., 662 8 Rinker-Schaeffer, C.W., Shahed, A., 960 Fefilli, M.V., 925 ego ages Rittenhouse, H.G., 4, 220, Shalhav, A.L., 366, 437, 590, Tekyi-Mensah, S., 325 Wei, J.T., 607, 945, 994 : Rivosecchi, M., 367 744 Terrell, F., 1017 Weichselbaum, R.R., 700, 875 Roach, M., III, 1049 Shames, D., 323 Terris, M.K., 486, 706 Weidner, W., 988 Roberts, J.L., 924 Shapiro, R., 366 Terzolo, M., 612 Weinberg, V.K., 1049 Robertson, J.L., 709 Sharp, D.S., 869 Tessier, J., 808 Weir, J., 424 Rodriguez, R., 401, 561 Shefi, S., 744 Tewari, A., 945 Weiss, R.E., 162, 208 Rodvold, D.M., 787 Shekarriz, B., 359, 964, Texter, J.H., 1058 Whatley, T., 1035 Roehrborn, C.G., 662 Shekarriz, H., 964 Thomas, A.J., Jr, 894 White, C., 420 Roessler, W., 247 Shimazaki, J., 313 Thoms, W.W., 561 White, R.V., 662 Rollema, H.J., 278 Shinghal, R., 706 Thornby, J.1., 976 Whitmore, K.E., 982 Rosen, R.C., 346 Shingleton, W.B., 1017 Thorning, D.R., 366 Wieland, W.F., 247 UROLOGY 54 (6), 1999 WWWWWiiiiiljleklkdnlisbeuaternmrr,dasg ,,,e Jr.,HSBN.. ..,J,P . J.,9.9, E2 7.11, 20 639450 0 WWWWWruuooinurogd,tdheh trri,uJln. im,g cGt,2ho .8,n4L , D.. HL,J..D,r ,. ,, 41232033056 ,86 839 “YYYYeioesptki,lmo laySin,.a ,Km. CaH.,.R,., J 9.O,0.3 5,66 31 972 9 ZZZZehaeicartcnmlagiarn,na, n , ,YS. .AH1...D,,, . -93H716.967,,3 493630 Williams, C.B., 384 Yoo, J.J., 407 Ziada, A.M., 6A-1 Williams, W.H., 968 Yoon, S.H., 148 Ziaja, E.L., 111 Yamanaka, K., 56 Yortikoglu, K., 50 Winter, D.L., 178 Zimmern, P.E., 37, 461 Winter, K., 495 Yamanishi, T., 65 Yoshida, K.-I., 1078 Zimny, M., 900 Witte, M.N., 869 Yang, T., 164 Yoshida, O., 313 Zincke, H., 105, 479 Wolfert, R.L., 220, 839 Yang, X.J., 528 Yoshiyama, M., 929 Zippe, C.D., 308, 583, 884 Wolfram, R., 603, 846 Yano, M., 1078 Young, C.Y.-F., 839 Zlotta, A., 517 WWoooldm,a n,D .P.I.,, 2Jr6,8 964, 1044 YYYeaaeos;,u daCS.,.,- L.7K,.4 ,6 3 6015 2 YYYuuo,su DnGg=.,SW :.,,M . J.33,74 74 6 A-8 ZZZvluaortrataka,,o wPAs..k,R i.4,,1 ] 3D8.2,, 52834 6 UROLOGY 54 (6), 1999 SUBJECT INDEX Antibiotics, quinolone, intravesical chemotherapy for bladder cancer, 56 (Page numbers in the Supplement to the December issue are Antimicrobial impregnated bladder catheters, catheter- associated bacteriuria, 976 preceded by a “6A-”). Antioxidant activities, rat testis, chronic cocaine administration, 925 Ablatherm device, transrectal high-intensity focused Anuria, infant, bilateral nephrolithotomy for multiple ultrasound, localized prostate carcinoma, 273 cystine stones in infants with, 366 Acid-base balance, urinary intestinal orthotopic reservoir, Apoptosis, paclitaxel-induced, signaling network, in LNCaP ileocecal neobladder compared with ileal neobladder, prostate cancer cell line, 746 629 Azoospermia, idiopathic, CAG repeat length androgen Acid secretion, gastric pouch, physiologic digestive function, receptor gene, 1073 50 5. Adenocarcinoma detection, urinary microsatellite analysis, augmentation Bacille Calmette-Gueérin cystoplasty, 561 alteration of immune profile in interstitial cystitis, exstrophic bladder, 744 cytokine levels in, 450 prostate stage T1 grade 3 bladder cancer therapy, 258 mucinous carcinoma, 141 Bacteriuria pathologic stage T3, recurrence, microvessel density, asymptomatic, children, lack of morbidity, urodynamic 479 studies, 359 Adrenal incidentaloma, follow-up, ultrasonography, 612 catheter-associated, antimicrobial impregnated bladder Adrenal metastasis, contralateral, renal cell carcinoma catheter, 976 nephrectomy, 162 Bcl-2 gene, targeting, to delay androgen-independent solitary metachronous, 162 progression and enhance chemosensitivity in prostate Adrenalectomy, ipsilateral, radical nephrectomy, renal cell cancer using antisense Bcl-2 oligonucleotides, 6A—36 carcinoma (letter), 193 Behcet’s syndrome, left ventricular aneurysm, ruptured renal Age artery pseudoaneurysm, 162 disease recurrence after radical prostatectomy, 533 Beta-(2 methoxyphenoxy)-lactic acid, carboxylate salt, radical prostatectomy complications and short-term excess, guaifenesin abuse, urolithiasis, 23 mortality, 301 Beta-trace protein, glomerular filtration rate (letter), 940 sexual function decline in Japanese men compared with Bicalutamide (Casodex) American men, 335 -induced prostate regression, increased expression of total and transition zone prostate volume and, PSA-based genes encoding insulin-like growth factor binding diagnostic parameters for early prostate cancer, 846 protein, 1120 Alpha-blockade metastatic prostate cancer, rapid disease progression, / 45 benign prostatic hyperplasia, 776 relative potency (letter), 194 neoadjuvant and adjuvant, high-energy transurethral Biochemical control rates, treatment for prostate cancer, microwave thermotherapy, compared with temporary caution in interpreting, follow-up length influences transurethral prostatic bridge-catheter, 73 875 response, benign prostatic hyperplasia, magnetic Biochemical failure resonance imaging, 829 overall survival, radical prostatectomy for localized uroselective, benign prostatic hyperplasia, 773 prostate cancer, 884 Amebiasis, genital, 952 prostate-specific antigen-based, 700 American men, decline in sexual function with age, Bladder compared with Japanese men, 335 augmentation, ventriculoperitoneal shunt infection, 356 Ammonium transport, in intestine exposed to urine, 373 compression, extrinsic, pubic bone spur (images), 919 Analgesia, extracorporeal shock wave lithotripsy evacuation, magnetic stimulation, 368 Medstone STS lithotriptor, 625 microtacks, pelvic laparoscopic surgery, 162 transcutaneous electrical nerve stimulation, 433 mucosal cell abnormalities, symptomatic outcome, Androgen deprivation, prostate cancer, 6A—15 transurethral resection of prostate, 834 bone density loss, 607 neuropathic, ileovesicostomy, advantages and risks, 636 chronic, serum testosterone-based luteinizing hormone- Bladder cancer releasing hormone agonist redosing schedule, 694 adenocarcinoma, exstrophic bladder, 744 testicular (letter), 194 immunolocalization of inducible and constitutive nitric Androgen-independent progression, in prostate cancer oxide synthase, +16 delay, targeting Bcl-2 gene, using antisense Bcl-2 spina bifida patient, 923 oligonucleotides, 6A-—36 Bladder cancer diagnosis Androgen receptor gene, CAG repeat length, idiopathic transitional cell carcinoma, rapid test, 656 azoospermia, 1073 urinary cytology consultation, 62 Androgen suppression, postoperative irradiation efficacy, Bladder cancer prognosis RTOG 85-31 analysis, 495 high-grade T1, angiogenesis, immunoreactivity ol Aneurysm, left ventricular, Behcet’s syndrome with, 162 cathepsin D, collagen type IV, 50 Angiogenesis, high-grade stage T1 primary bladder cancer Bladder cancer risk prognosis, 50 tea consumption, fluid intake and, 823 Angiography, Doppler, contrast-enhanced three-dimensional Bladder cancer treatment power, human prostate, correlation with biopsy bacille Calmette-Guérin, in stage T1 grade 3 cancer, 258 outcome, 97 intravesical chemotherapy, quinolone antibiotics, 56 Anti-androgens, prostate cancer, 6A—15 intravesical pertussis toxin, +58 © 1999, ELsEvIER SCIENCE IN¢ 0090-4295/99/$20.00 ALL RIGHTS RESERVED PIL SOO90-4295(99)00525-7 1135 photodynamic therapy, calphostin C, in vitro evaluation, Cerebral abscess, and Citrobacter diversus urosepsis, in child 573 with antenatal hydronephrosis, 1097 Bladder dysfunction, neurogenic, incontinent Chemotherapy, prostate cancer ileovesicostomy, 1008 adjuvant, trials, urologist role, 6A-47 Bladder inflammation, luminal nitric oxide measurement hormone-refractory, urologist role, 6A—51 using silicon balloon catheter, 264 Ciprofloxacin, intravesical chemotherapy for bladder cancer, Bladder outlet obstruction 56 diagnosis, clinical prostate score, prostate measurement Citrobacter diversus urosepsis and cerebral abscess in child and uroflowmetry, 90 with antenatal hydronephrosis, 1097 in men, pressure-flow parameters, finasteride Cleveland Clinic, experience with penile fracture, 352 improvement of, 278 Cloaca, persistent, prenatal diagnosis, 367 partial, induced contractile dysfunction, sucrose diuresis Cocaine administration, chronic, lipid peroxidation and protection,, 183 antioxidant activities, rate testis, 925 Bladder replacement, gastric segment, acid secretion, 553 Cocktail modulator mixtures, multidrug resistance in renal Blood pressure, terazosin effects, benign prostatic cell carcinoma, 377 hyperplasia, concurrent antihypertensives, 81 Collagen injection Blood transfusion, autologous periurethral, female stress urinary incontinence, 815 percutaneous nephrolithotomy, +44 prostatectomy incontinence, 597 radical retropubic prostatectomy, cardiopulmonary risk, Collagen matrix, acellular, biomaterial for urethral repair, 407 130 Collagen type IV, high-grade stage T1 primary bladder Bone density loss, androgen deprivation, 607 cancer prognosis, 50 Bone marrow magnetic resonance imaging, high-risk Colposuspension, Burch, long-term results, and review of prostate cancer, 118 published reports, 808 Book reviews Computed tomography Atlas of Erectile Dysfunction, An, 942 abdomen and pelvis, prostate cancer staging, 490 Color Atlas of Endourology, 580 three-dimensional reconstruction, renal artery thrombosis, Erectile Dysfunction, 580 559 Glenn’s Urologic Surgery, 5th ed., 942 Continence rates, urodynamic parameters, continent urinary Interstitial Cystitis, 198 reservoirs, comparison of segments, 252 Brachytherapy Continent stoma procedure, laparoscopic-assisted, pediatric, permanent, recurrent prostate cancer salvage treatment, 909 880 Contractile dysfunction, partial bladder outlet obstruction- salvage induced, sucrose diuresis protection, 183 radiorecurrent prostate cancer, 204 Costs, hospital, radical nephrectomy versus nephron-sparing rising PSA, external beam radiation therapy, 201 surgery, renal cell carcinoma, 994 BRCA1-like immunoreactivity of human seminal plasma, Crural venous leakage, surgery, 739 characterization, 753 Cryoablation, prostate cancer, patient-reported Brown, James, catheterization of male ureter: June 9, 1893, complications, 300 188 Cryopreservation, sperm, testicular cancer, 894 Burn scar, squamous cell carcinoma at base of penis, 923 Cryosurgery prostate cancer, improved glandular ablation, 6 to 8 cryoprobes, 135 CAG repeat length, androgen receptor gene, idiopathic renal, 215 azoospermia, 1073 Culdosuspension, transvaginal, technique and results, 819 Calphostin C, bladder cancer photodynamic therapy, in Cyst vitro evaluation, 573 epidermoid, scrotum, extending into true pelvis, 561 Capromab pendetide, indium-111 immunoscintigraphy, prostatic, intraurethral, anterior, clinical features and prostate cancer, 1058 management, 923 testicular, simple, and teratoma, first year of life, 366 Cardiopulmonary risk, preoperative autologous blood Cystine stones, multiple, in infant with anuria, bilateral donation radical retropubic prostatectomy, 130 nephrolithotomy, 366 Casodex. See Bicalutamide Cystocele, paravaginal defect repair, 647 Castration, early, prostatic carcinogenesis in transgenic Cystoplasty, augmentation, adenocarcinoma detection, mice, 1112 urinary microsatellite analysis, 561 Cathepsin D, immunoreactivity, high-grade stage T1 Cystoscopic light test, differentiation of high grade pelvic primary bladder cancer prognosis, 50 organ prolapse, 1084 Catheter Cystoscopy introducer sheath, flexible ureteroscopy, 557 -associated bacteriuria, antimicrobial impregnated bladder Cytokine levels, urinary, interstitial cystitis, intravesical catheters, 976 bacille Calmette-Guérin alteration of immune profile, balloon, silicon, luminal nitric oxide in bladder 450 inflammation using, 264 Cytomegalovirus infection, native ureter, after liver-kidney hydrogel/silver ion-coated, nosocomial urinary tract transplantation, 366 infection rates, intensive care unit patients, 982 intraurethral prostatic bridge, temporary, compared with neoadjuvant and adjuvant alpha-blockade, high- Diet, benign prostatic hyperplasia, 284 energy transurethral microwave thermotherapy, 73 Digestive function, physiologic, gastric pouch acid secretion, Catheterization, male ureter, Dr. James Brown and: June 9, 553 1893, 188 Digital rectal examination. See Rectal examination CD44 adhesion molecules, expression, in nonpapillary renal Diuresis, sucrose, bladder outlet partial obstruction-induced cell carcinoma and normal kidneys, 562 contractile dysfunction protection by, 183 1136 UROLOGY 54 (6), 1999 Docetaxel, pharmacokinetics and pharmacodynamics, Gastric carcinoma, metastasis, ureter, 561] 6A-22 Gastric pouch acid secretion, physiologic digestive function, Doppler angiography, contrast-enhanced three-dimensional 553 power, human prostate, correlation with biopsy Gene therapy outcome, 97 pro-drug, prostate cancer, 1098 urologic applications, 401] Electrolyte balance, urinary intestinal orthotopic reservoir, Genital amebiasis, 952 ileocecal neobladder compared with ileal neobladder, Germ cell tumors 629 nonseminomatous, low-stage, retroperitoneal lymph node Endocrine therapy, stages B2 and C prostate cancer, radical dissection, retroperitoneal recurrences, 548 prostatectomy versus external beam radiation testicular therapy, long-term results of randomized trial for, bilateral, clinical course and histopathologic risk factor 313 assessment, 714 Endopyelotomy clinical stage I, nonseminomatous, laparoscopic outcome, high versus dependent ureteral insertion, 999 retroperitoneal lymph node dissection, 1064 retrograde, active distal ureteral dilation, 7F ureteral “tail” Gleason score 7, small foci, prostate cancer needle biopsy stent, 744 328 Endoscopy, reconstruction of vesicourethral obliteration, Glomerular filtration rate, beta-trace proteins (letter), 940 retropubic prostatectomy, 913 Gonadoblastoma, false-positive pregnancy test, 162 Endothelial growth factor, vascular, plasma levels, metastatic Gore-Tex patch sling, long-term results, 641 prostate cancer, 523 Guaifenesin, abuse, carboxylate salt of beta-(2 Endothelial growth factor receptors, vascular, expression in methoxyphenoxy)-lactic acid excess, urolithiasis, 23 human prostate cancer, 567 Gunshot injuries, renal, 972 Epidermoid cyst, scrotum, extending into true pelvis, 561 Epithelial cells, prostate, vitamin D differential effects, 171 Hematuria Epithelial tumor, Millerian-type, torsed appendix testis, 561 Merkel cell tumor metastatic to bladder, 163 Erectile dysfunction. See also Sildenafil urethral polyp in male infant, 921 after radiation therapy for prostate cancer, sildenafil Hernia, ureterosciatic, laparoscopic repair, 730 citrate (Viagra) treatment, 308 Hormonal therapies oral pharmacotherapy, 392 prostate cancer, 6A—15 psychological factors, DSM-IV diagnosis, sildenafil citrate prostate-specific antigen levels, 325 (letter), 579 Hydrogel/silver ion-coated urinary catheter, nosocomial testing urinary tract infection rates, intensive care unit intracavernous prostaglandin E,, variable response, 539 patients, 982 questionnaires replacing, 719 Hydro-jet dissection, laparoscopic nephrectomy, 964 vacuum constriction devices, 891] Hydrometrocolpos. inadvertent perivaginal placement of Erectile function domain, International Index of Erectile artificial urinary sphincter, 923 Function, diagnostic evaluation, 346 Hydronephrosis, antenatal, Citrobacter diversus urosepsis Ethanol, absolute, transurethral intraprostatic injection and cerebral abscess, 1097 infection, ablation of canine prostate, 411] Hyperechogenicity, renal medullary, of neonate, 365 Ethical considerations in fetal urology, 1093 Hypospadias Eulexin. See Flutamide complications, repair, previously utilized urethra | pI late, 724 Fascial sling, erosion into urethra, 923 repair, tubularized incised plate, 6 Females. See women Fetal urology. See also Pediatric urology Ileal neobladder diamniotic twin gestation discordant for renal dysplasia -enteric fistula, conservative management, 366 and oligohydramnios, 1097 orthotopic, voiding function, in women, 44 ethical considerations, 1093 Ileovesicostomy, neuropathic bladder prenatal karyotype and ultrasound discordance in advantages and risks, 636 intersex, 1097 incontinent, 1008 1 Fibrosis, penile, penile implant, multiple incisions, minimal Immunoreactivity, BRCA1-likiek , of human seminal plasma, scar tissue excision, 145 characterization, 75 3 Finasteride Immunoscintigraphy, 111-In capromab pendetide, prostate bother and other health-related quality of life aspects, cancer, 1058 benign prostatic hyperplasia, 670 Immunotherapy, adoptive, T-cell, metastatic renal cell improvement in pressure-flow parameters in men, 278 carcinoma, 617 long-term changes in symptoms and flow rate, versus Incontinence, urinary. See also Surgery, anti-incontinence placebo, 662 intractable, children Fistula, ileal neobladder-enteric, conservative management, myofascial wrap (letter), 383 366 prostatectomy, collagen injection, 597 FK506, toxic levels, stuttering priapism in liver transplant stress patient with, 366 female, paravaginal defect repair, 647 Flank incision, renal donors, morbidity, 796 female, periurethral collagen injection, 815 Fluid consumption, tea consumption, bladder cancer risk, persistent, quality of life after suspension procedures, 823 247 18-Fluoro-deoxyglucose, positron emission tomography, pubovaginal sling, ideourodynamic results, 802 clinical staging of testicular cancer, 900 urge Flutamide (Eulexin), relative potency (letter), 194 oxybutynin once-daily formulation, evaluation, +20 UROLOGY 54 (6), 1999 1137 Indium-111-capromab pendetide immunoscintigraphy, Laser ablation of prostate, versus transurethral resection of prostate cancer, 1058 prostate, benign prostatic hyperplasia, 1017 Infection Length-of-stay cytomegalovirus, native ureter, after liver-kidney hospital, radical nephrectomy versus nephron-sparing transplantation, 366 surgery, renal cell carcinoma, 994 nosocomial, rates, urinary tract, intensive care unit Leydig cell tumor, testis, organ-sparing bilateral surgery, 744 patients, hydrogel/silver ion-coated catheter, 982 Lipid peroxidation, rat testis, chronic cocaine upper urinary tract, advanced, percutaneous administration, 925 nephrostomy, 234 Lithotripsy, extracorporeal shock wave ventriculoperitoneal shunt, bladder augmentation, 356 analgesia Infertility, testicular cancer, sperm cryopreservation, 894 Medstone STS lithotriptor, 625 Inflammation transcutaneous electrical nerve stimulation, 433 bladder, measurement of luminal nitric oxide using rate of shock delivery, stone fragmentation, 430 silicon balloon catheter, 264 Liver-kidney transplantation, cytomegalovirus infection of high-grade, prostate cancer, prognostic factor for native ureter, 366 biochemical recurrence, radical prostatectomy, 467 Liver transplant patient, stuttering priapism, toxic levels of Infrarenal vena caval tumor thrombus, renal cell carcinoma, FK506, 366 561 Lower urinary tract symptoms, phytotherapeutic agents, Insulin-like growth factor 1, prostate-specific antigen ratio, analysis and awareness of use, 86 prostate cancer detection, 603 Luteinizing hormone-releasing hormone agonist, Insulin-like growth factor binding protein, genes encoding, testosterone-based, plasma, redosing schedule, increased expression, bicalutamide-induced prostate chronic androgen ablation, 694 regression, 1120 Luteinizing hormone-releasing hormone analogue, radical Insulin-like growth factor binding protein-2, high risk prostatectomy failure after, tumor cell proliferation, prostate cancer development, racial differences, 178 329 Intensive care unit patients, nosocomial urinary tract Lymphoma infection, hydrogel/silver ion-coated catheters, 982 non-Hodgkin’s. See Non-Hodgkin’s lymphoma International Index of Erectile Function, diagnostic penile, primary, diagnostic difficulties and management evaluation of erectile function domain, 346 options, 366 Intersex, ultrasound discordance, prenatal karyotype and, 1097 Intestinal orthotopic reservoir. See Urinary intestinal Magnetic resonance imaging orthotopic reservoir alpha-blocker response in benign prostatic hyperplasia, Intestine, exposed to urine, ammonium transport, 373 829 Intraepithelial neoplasia, prostatic. See Prostatic bone marrow, high-risk prostate cancer, 118 intraepithelial neoplasia dynamic, grading pelvic prolapse and pelvic floor Intraurethral prostatic bridge-catheter, temporary, compared relaxation, 454 with neoadjuvant and adjuvant alpha-blockade, high- voiding dysfunction, in children, 157 energy transurethral microwave thermotherapy, 73 Magnetic stimulation Inventory-6 Questionnaire, urodynamic findings, evacuation of neuropathic rectum and urinary bladder, predictability, +61 368 functional continuous, urethral closure, 652 Japanese men, decline in sexual function with age, compared Men with American men, 335 Japanese, decline in sexual function with age, compared with American men, 335 pressure-flow parameters, finasteride improvement of, 278 Kallikrein 2, human glandular, prostate cancer detection, Merkel cell tumor, metastatic to bladder, hematuria, 163 839 Microtacks, bladder, laparoscopic pelvic surgery, 162 Karyotype, prenatal, and ultrasound discordance in intersex, Microvessel density, pathologic stage T3 prostate 1097 adenocarcinoma recurrence, 479 Kidney Micturition, changes, spinal cord injury, 929 normal, CD44 adhesion molecules expression, 562 Monti procedure, as continent catheterizable stoma, 152 polycystic disease, autosomal recessive, prenatally Mortality, radical prostatectomy, short-term, age and diagnosed, initial postnatal management, 1097 surgical approach, 301 Kidney transplant recipients Mucinous carcinoma, prostate, 141 See Renal transplant recipients Mucosal cell abnormalities, bladder, symptomatic outcome, transurethral resection of prostate, 834 Lambert-Eaton myasthenic syndrome, transitional cell Mullerian-type epithelial tumor, torsed appendix testis, 561 carcinoma, 162 Myasthenic syndrome, Lambert-Eaton, transitional cell Laparoscopic surgery carcinoma, 162 continent stoma procedure, pediatric, 909 Myofascial wrap, intractable urinary incontinence, in nephrectomy children (letter), 383 Hydro-Jet dissection, 964 xanthogranulomatous pyelonephritis, 437 open access, radially dilating trocar sleeve, 727 Narcotic-seeking behavior, urolithiasis, 744 pelvic, bladder microtacks, 162 National Institutes of Health, First International Prostatitis retroperitoneal lymph node dissection for clinical stage | Collaborative Network, consensus report, on nonseminomatous germ cell testicular tumors, 1064 research guidelines for chronic prostatitis, 229 ureterosciatic hernia, 730 Needle biopsy. See Prostate biopsy 1138 UROLOGY 54 (6), 1999

ebook img

Urology 1999: Vol 54 Index PDF

17 Pages·1999·6.3 MB·English
by  
#periodicals #sim_microfilm #pub_urology
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Urology 1999: Vol 54 Index

VOLUME 54, JULY TO DECEMBER 1999 UROLOGY Pages Issue Pages Issue 1-200 July 583-772 October 201-384 August 173-944 November 385-582 September 945-1144 December 6A1—6A52 December Supplement AUTHOR INDEX Aarnink, R.G., 97 Barbaric, Z.L., Buell, U., 900 Christiano, A.P., 86, 162 Abrahamsson, P.-A., 329 Barrett, D.M.., Bukowski, R.M., 617 Chung. T:, 573 Abrams, P., 278 Barthold, J.S., Bukowski, T.P., 1093 Civantos, F., 533, 682 Acar, O:,553 Basharkhah, A., 18, 73, 603 Bull, C.A., 124 Clayman, R.V., 366, 437, Adam, R.M., 523 Bauerfeind, P., 553 Burgers, J.K., 1058 590, 744, 767 Adami, H.-O., 284 Becich, M.J., 171 Burnett, A.L., 392, 580 Cochran, S.T., 919 Adams, K., 124 Becks U.P, 973 Burno, D.K., 162 Collins, D.R., 162 Adams, M.C., 724 Beerlage, H.P., 97, 273 Burns, M., 162 Colombeau, P., 744 Addicks, K., 416 Benedetti, G., 629 Bursa, B., 18, 73, 603, 846 Comiter, C.V., 454, 819, 1085 Agarwal, A., 308, 894 Bengtsson, E., 862, 1028 Busch, C., 862, 1028 Condie, J.D., Jr, 1012 Ahlgren, G., 329 Benson, M.C., 490, 852 Butler, R., 561 Connell, P.P., 875 Akakura, K., 313 Benton, J.B., 968 Connolly, S., 162 Akgiin, Y., 972 Bercowsky, E., 366, 437 Cooney, K.A., 607 Akimoto, S., 313 Bergman, J., 1003 Cooper, C.S., 162 Akino, H., 763 Bergner, D., 662 Cadeddu, J.A., 909 Coquet, A., 194 Albani, J., 869 Bergstralh, E.J., 105, 479 Cain, M.P., 724, 923 Corcos, J., 815 Albers, P., 714 Berman, J.R., 385, 578 Candas, B., 194 Corica, A., 67 Albertsen, P., 301 Berman, L., 385 Canning, D.A., 162 Corica, F.A., 67 Albertsen, P.C., 567 Berry, M.P., 124 Cannon, A., 278 Corn, B.W., 495 Alcini, A., 629 Cappelleri, J.C., 346 Cornel, E.B., 366 Alcini, E., 629 Bertrand, P.E., 808 Capristo, E., 629 Coulange, C., 857 Ali, A., 612 Bex, A., 458 Carducci, M.A., 745 Crawford, E.D., 6A-1, 6A-51 Beyer, D.C., 880 Cremerius, U., 900 Altmannsberger, M., 988 Carr, M., 366 Bhargava, V., 689 Crisci, A., 923 Al-Uzri, A., 1097 Carroll, P.R., 1049 Bierhoff, E., 714 Critz, F.A., 968 Ambuthl, P.M., 55 3 Cartei, G., 923 Bilancioni, E., 367 Cromie, W.J., 917 Amling, C.L., 924 Carter, H.B., 291, 780 Billings, EJ., 163 Cummings, G.D., 1044 An, G., 1105 Casale, A.J., 724 Bishoff, J.T., 1064 Cutherell, L., 1012 Andersen, J.T., 278 Case, D., 853 Blander, D.S., 719 Andriole, G.L., 194 Castellan, M.A., 152 Bloch, W., 416 Ang, P.C.S., 363 Catalona, W.J., 220, 839 Bloom, D.A., 767 Angeli, A., 612 Cathomas, G., 553 Blute, M., 479 D’Addessi, A., 629 Angelopoulou, K., 753 Cespedes, R.D., 198, 548, 597 Blute, M.L., 105 Dadds, L., 834 Angermeier, K.W., 352 Chaikin, D.C., 806 Bogers, H.A., 97 D’Amico, A.V., 201 Antony, S.J., 952 Chan, D.W., 4, 220, 839 Bologna, R.A., 982 Darouiche, R.O., 976 Aoki, Y., 225 Chan, D.Y., 1088 Bolton, S., 325 Darras, F.S., 162 Arai, Y., 44, 22 Me 3 |e: Boone, T., 466 Chancellor, M.B., 636, 929 Darte, C., 839 Arakawa, S., 56 Chang,J. , 164 Boone, T.B., 976 David, M.P., 268 Arcadi, J.A., 18 Chang, S.-Y., 377 Anikan, N., 157, 905 BBoorrcbhoerrosg,l u,H. , P.9G0.0, 924, 1097 Charles, L.G., 1112 DDaayy,, KM..CL..,, 774466 Atala, A., 407 Chatelain, C., 473 De Antoni, P., 923 Atan, A., 636 Borchert, G., 753 Chaussy, C., 273 Debruyne, F.MJ., 97, 273 Atkinson, G., 1098 Bostwick, D.G., 67, 479 Cheah, F-K., 363 de Gier, R.P.E., 366 Aus, G., 329 Bourg, S., 744 Chekmareva, M.A., 162 DeHaven, J.I., 56 Autet, W., 473 Boyle, P., 662 Chen, F., 407 Delaere, K.P.J., 561 Awan, A., 700 Brabbins, D.S., 111 Chen, M.-H., 700 de la Rosette, J.J.M.C.H., 97, Bracken, R.B., 662, 670 Chen, R.N., 1064 23 Brackman, F., 473 Cheng, L., 67 de la Taille, A., 1039 Brame, M., 1097 Chiaccherini, R.P Destefanis, P., 612 Babaian, R.J., 976 Brandt, J.M., 787 Chiba, K., 1078 DeWolf, W.C., 163 Bach, M.A., 278 Brawer, M.K., 2 Chin, N.W., 744 Dhabuwala, C.B., 145, 925, 976 Badalament, R.A., 135, 295 Brendler, C.B., 162, 940 Chinn, D.O., 135 Diamandis, E.P., 753, 941 Bagiella, E., 490, 1039 Bright, S.P., 1105 Chmiura:SJ., 573 Dilger, J.A., 130 Bagolan, P., 367 Broberg, J., 853 Cho, J.S., 164 Diokno, A.C., 450 Bahn, D.K., 135, 295 Broderick, G.A., 719 Choe, J.M., 641 Ditropan XL Study Group, 420 Bahn, J.M., 295 Bruce, R.G., 647 Chow, G.K., 999 Djavan, B., 18, 73, 517, 603, Balcom, A.H., 366 Bruch, H.-P., 964 Chow, N.-H., 561 846 Bales, G.T., 86 Bruskewitz, R., 278, 670 Ghrisp; G:E., 1142 Dmochowski, R.R., 43 © 1999, ELsevieR SCIt NCE INC. 0090-4295/99/$20.00 1130 ALL RIGHTS RESERVED PIL SOO090-4295(99)00524-5 VOLUME 54, JULY TO DECEMBER 1999 UROLOGY Pages Issue Pages Issue 1-200 July 583-772 October 201-384 August 173-944 November 385-582 September 945-1144 December 6A1—6A52 December Supplement AUTHOR INDEX Aarnink, R.G., 97 Barbaric, Z.L., Buell, U., 900 Christiano, A.P., 86, 162 Abrahamsson, P.-A., 329 Barrett, D.M.., Bukowski, R.M., 617 Chung. T:, 573 Abrams, P., 278 Barthold, J.S., Bukowski, T.P., 1093 Civantos, F., 533, 682 Acar, O:,553 Basharkhah, A., 18, 73, 603 Bull, C.A., 124 Clayman, R.V., 366, 437, Adam, R.M., 523 Bauerfeind, P., 553 Burgers, J.K., 1058 590, 744, 767 Adami, H.-O., 284 Becich, M.J., 171 Burnett, A.L., 392, 580 Cochran, S.T., 919 Adams, K., 124 Becks U.P, 973 Burno, D.K., 162 Collins, D.R., 162 Adams, M.C., 724 Beerlage, H.P., 97, 273 Burns, M., 162 Colombeau, P., 744 Addicks, K., 416 Benedetti, G., 629 Bursa, B., 18, 73, 603, 846 Comiter, C.V., 454, 819, 1085 Agarwal, A., 308, 894 Bengtsson, E., 862, 1028 Busch, C., 862, 1028 Condie, J.D., Jr, 1012 Ahlgren, G., 329 Benson, M.C., 490, 852 Butler, R., 561 Connell, P.P., 875 Akakura, K., 313 Benton, J.B., 968 Connolly, S., 162 Akgiin, Y., 972 Bercowsky, E., 366, 437 Cooney, K.A., 607 Akimoto, S., 313 Bergman, J., 1003 Cooper, C.S., 162 Akino, H., 763 Bergner, D., 662 Cadeddu, J.A., 909 Coquet, A., 194 Albani, J., 869 Bergstralh, E.J., 105, 479 Cain, M.P., 724, 923 Corcos, J., 815 Albers, P., 714 Berman, J.R., 385, 578 Candas, B., 194 Corica, A., 67 Albertsen, P., 301 Berman, L., 385 Canning, D.A., 162 Corica, F.A., 67 Albertsen, P.C., 567 Berry, M.P., 124 Cannon, A., 278 Corn, B.W., 495 Alcini, A., 629 Cappelleri, J.C., 346 Cornel, E.B., 366 Alcini, E., 629 Bertrand, P.E., 808 Capristo, E., 629 Coulange, C., 857 Ali, A., 612 Bex, A., 458 Carducci, M.A., 745 Crawford, E.D., 6A-1, 6A-51 Beyer, D.C., 880 Cremerius, U., 900 Altmannsberger, M., 988 Carr, M., 366 Bhargava, V., 689 Crisci, A., 923 Al-Uzri, A., 1097 Carroll, P.R., 1049 Bierhoff, E., 714 Critz, F.A., 968 Ambuthl, P.M., 55 3 Cartei, G., 923 Bilancioni, E., 367 Cromie, W.J., 917 Amling, C.L., 924 Carter, H.B., 291, 780 Billings, EJ., 163 Cummings, G.D., 1044 An, G., 1105 Casale, A.J., 724 Bishoff, J.T., 1064 Cutherell, L., 1012 Andersen, J.T., 278 Case, D., 853 Blander, D.S., 719 Andriole, G.L., 194 Castellan, M.A., 152 Bloch, W., 416 Ang, P.C.S., 363 Catalona, W.J., 220, 839 Bloom, D.A., 767 Angeli, A., 612 Cathomas, G., 553 Blute, M., 479 D’Addessi, A., 629 Angelopoulou, K., 753 Cespedes, R.D., 198, 548, 597 Blute, M.L., 105 Dadds, L., 834 Angermeier, K.W., 352 Chaikin, D.C., 806 Bogers, H.A., 97 D’Amico, A.V., 201 Antony, S.J., 952 Chan, D.W., 4, 220, 839 Bologna, R.A., 982 Darouiche, R.O., 976 Aoki, Y., 225 Chan, D.Y., 1088 Bolton, S., 325 Darras, F.S., 162 Arai, Y., 44, 22 Me 3 |e: Boone, T., 466 Chancellor, M.B., 636, 929 Darte, C., 839 Arakawa, S., 56 Chang,J. , 164 Boone, T.B., 976 David, M.P., 268 Arcadi, J.A., 18 Chang, S.-Y., 377 Anikan, N., 157, 905 BBoorrcbhoerrosg,l u,H. , P.9G0.0, 924, 1097 Charles, L.G., 1112 DDaayy,, KM..CL..,, 774466 Atala, A., 407 Chatelain, C., 473 De Antoni, P., 923 Atan, A., 636 Borchert, G., 753 Chaussy, C., 273 Debruyne, F.MJ., 97, 273 Atkinson, G., 1098 Bostwick, D.G., 67, 479 Cheah, F-K., 363 de Gier, R.P.E., 366 Aus, G., 329 Bourg, S., 744 Chekmareva, M.A., 162 DeHaven, J.I., 56 Autet, W., 473 Boyle, P., 662 Chen, F., 407 Delaere, K.P.J., 561 Awan, A., 700 Brabbins, D.S., 111 Chen, M.-H., 700 de la Rosette, J.J.M.C.H., 97, Bracken, R.B., 662, 670 Chen, R.N., 1064 23 Brackman, F., 473 Cheng, L., 67 de la Taille, A., 1039 Brame, M., 1097 Chiaccherini, R.P Destefanis, P., 612 Babaian, R.J., 976 Brandt, J.M., 787 Chiba, K., 1078 DeWolf, W.C., 163 Bach, M.A., 278 Brawer, M.K., 2 Chin, N.W., 744 Dhabuwala, C.B., 145, 925, 976 Badalament, R.A., 135, 295 Brendler, C.B., 162, 940 Chinn, D.O., 135 Diamandis, E.P., 753, 941 Bagiella, E., 490, 1039 Bright, S.P., 1105 Chmiura:SJ., 573 Dilger, J.A., 130 Bagolan, P., 367 Broberg, J., 853 Cho, J.S., 164 Diokno, A.C., 450 Bahn, D.K., 135, 295 Broderick, G.A., 719 Choe, J.M., 641 Ditropan XL Study Group, 420 Bahn, J.M., 295 Bruce, R.G., 647 Chow, G.K., 999 Djavan, B., 18, 73, 517, 603, Balcom, A.H., 366 Bruch, H.-P., 964 Chow, N.-H., 561 846 Bales, G.T., 86 Bruskewitz, R., 278, 670 Ghrisp; G:E., 1142 Dmochowski, R.R., 43 © 1999, ELsevieR SCIt NCE INC. 0090-4295/99/$20.00 1130 ALL RIGHTS RESERVED PIL SOO090-4295(99)00524-5 Docimo, S.G., 358, 561, 727, Freedman, A.L., 359 Grob, B.M., 744 Irwin, R.J., Jr., 234 909 Freedman, G.M., 118 Grocela, LA, 375 Isaka, S., 313 Doebler, R.W., 366 Freeman, M.R., 523 Gross, M., 607 Ishikawa, N., 652 Domen, R.E., 130 Freese, R., 988 Grossfeld, G.D., 1049 Israeli, R.S., 208 Donehower, R.C., 1064 Fried, M., 553 Groutz, A., 268 Issa, M.M., 625, 923 Dotan, Z.A., 744 Frimmel, H., 862 Gruppo Piemontese Ito, H., 313 Douno, S., 829 Frischer, J., 1082 Incidentalomi Surrenalici, Iwaki,H ., 141 Drouin, J., 808 Fe %.235 612 Dukes, K.A., 424 Furr, B.J.A., 194 Gudziak, M.R., 1008 Dumas, J.P., 744 Fusilier, H.A., 670 Gunther, R.W., 900 Jacobs, G., 416 Dunbar, J.C., 925 Fussner, A.L., 23 Jacobsen, C.A., Duque, J.L.F., 523, 796 Jacobsen, > Ee. 3 Dutta, T.C., 891 Haas, C.A., 559 jaffa, A., 268 Dversdall, B.C., 23 Hachiya, T., 313 Jaffe, C.A., 607 Gal, A.A., 561 Hafez, K., 994 Jaffee, E.M., 623 Galloway, N.T.M., 647 Hahnfeld, L.E., 162 Jakse,G ., 900 Game, X., 923 Hald, T., 278 Jani. A.B., 700 Eastham, J.A., 709, 869, 1035 Garnick, M.B., 323 Hall, S.J., 1098 janitzky, V., 433 Gasser, T.C., 539 Eble, J.N., 561 Hallak, J., 894 Janulis, L., 164 Egevad, L., 862, 1028 Gatti, C., 367 Hamaguchi, A., 44 Jarow, J.P., 942 Eghazarian, C., 857 Gazi, M.A., 162 Han, K.-r., 162 Jasti, B.R., 6A-22 Ehrén, I., 264 Gearhart, J.P., 726 Handa, V.L., 923 Jerkins, G.R., 356 Eid, J.F., 891 Gee, J., 730 Hanks, G.E., 118, 178 Jhaveri, F.M., 884 Geisinger, M.A., 999 EFisenberger, M.A., 745 Hanlon, A.L., 178 Jiang, Y., 925 Gennaro, M.D., 367 Elbahnasy, A.M., 366, 437 Hanna, H., 976 John, H., 539 El-Galley, R., 625 Gerber, G.S., 86, 557 Hanna, M.K., 383 Johnson, D.B., 561 El-Galley, R.E.S., 647 Gershbaum, M.D., 34 Hara, I., 562 Johnson, E.L., 670 Elia, G., 1003 Gettman, M.T., 479 Hara, S., 562 Jones, K.A., 791 Emoto, A., 829 Getzenberg, R.H., 171 Harkaway, R.C., 366 Jordan, M., 366 Eng, M.H., 1112 Ghavamian, R., 105 Harmon, J].D., 366 Joseph, D.B., 362 Ghawidel, K., 18, 73, 846 Engel, J.D., 164 Hauri, D., 539, 553 Engelmann, U., 416 Gheiler, E.L., 1008 Hedican, S.P., 727 Ennis, R.D., 490 Giessing, M., 940 Hedlund, H., 278 Kaci, G., 539 Epstein, J.I., 291, 528, 791, 934 Gilchrist, B.F., 1082 Heesakkers, J.P.F.A., 561 Kakizoe, T., 313 Erden, I., 157 Gill, I.S., 215, 734 Hemal, A.K., 590 Kalble, T., 458 Ersay, A., 972 Ginsberg, P.C., 366 Hennenfent,M ., 229 Kalish, J., 923 Ertl, C.W., 162 Giorlandino, C., 367 Henning, J.M., 424, 503 Kalish, L.A., 1022 Esenler, A.C., 41] Girman, C.]., 335, 670 Herndon, C.D.A., 1097 Kamat, A.M., 56 Eskew, L.A., 853 Gittelman, M., 662 Herrero, E., 656 Kamidono, S., 562 Esposito, M., 234 Gleason, D.M., 420 Herulf, M., 264 Kamradt, J.M., 746 Gleave, M.E., 6A-36 Kanamaru, H., 763 Hickey, D.P., 923 Goégus, O., 157, 905 Kanba, T., 44 Hinkle, G.H., 1058 Goldfarb, D.A., 923 Kane, C.]., 744 Hinman, J., 1044 Fabozzi, S., 194 Goldie, J., 6A-36 Kantolf, P.W., 523, 1064 Hoenig, D.M., 590 Fabrizio, M.D., 442 Goldstein, I., 385, 578, 587 Kantor, $.D., 670 Holladay, C.T., 968 Faerber, G.J., 607 Goll, A., 714 Kaplan, S.A., 578, 776 Holladay, D.A., 968 Fanasca, A., 629 Gonzalez, J.A., 111 Kaplan, S.H., 424 Homsy, Y., 1097 Feitz, W.F.J., 366 Gonzalez, R., 359 Kapoor, A., 923 Honda, M., 1078 Fergany, A.F., 352 Goodwin, S., 164 Kardar, A.H., 193 Horan, P., 183 Ferguson, S., 23 Gordon, D., 268 Karpman, E., +11 Hosseini, A., 264 Ferrer, F.A., 567, 1097 Gordon, D.A., 982 Kasagi, Y., 829 "HrubyS,. . 18, 73, 846 Filbeck, T., 247 Gosalbez, R., Jr, 152 Kattan, M.W _ 709. 869 Hsieh, C.-C., 284, 823 Finasteride Urodynamics Goujon, J.-M., 467 Katz, A., 1039 Hsu, C.X., 1112 Study Group, 278 Gousse, A.E., 454 Kavoussi, L.R., 1064 Huang, A., 561 Finlay, J.A., 220, 839 Grado, G.L., 204 Kay, R., 994 Huang, C.-H., 823 Fiori, C., 612 Graham, S.D., Jr, 561 Kazimoglu, H., 50 Huang, J.-K., 823 Firlit, C.F., 383 Grainger, R., 162 Keating, M.A., 724 Hubert, J., +67 Fischer, C., 988 Gralnek, D., 1097 Kedia, A.W., 583 Hudes, G R., 118 Fishbain, D.A., 579 Grasso, M., 240 Kedia, S., 308, 583 Hugosson, J., 329 Flanders, S.C., 424, 503 Gravlin, K., 607 Kestin, L.L., 111 Hurle, R., 258 Flechner, $.M., 923 Gray, C.L., 744, 1097 Khair, A.A., 67 Hussain, M., 6A-22 Fleming, P., 359 Gray, T., 662 Khoury, A.E., 160 Fontana, D., 612 Greenberg, N.M., 1112 Kiel, H.J., 247 Forman, J.D., 325 Greenberger, M., 365 Kim, H., 295 Foster, B., 37 Greene, C., 135 Iczkowski, K.A., 67 Kim, H.L., 557 Fournier, C., 815 Greenfield, S., 424 Ignacio, L., 700, 875 Kim, S.-C., 148 Fowler, J., 670 Greenstein, A., 430 Induhara, R., 744 Kim, S.-]., 164 Fowler, J.E., Jr, 1017 Grignon, D., 1044 International Prostatitis Kim, S.W., 544 Fraiman, M., 240 Grmoljez, P., 679 Collaborative, 229 Kin, S., 44 Fraimow, H.D., 982 Groat, W.C., 929 Irani, J., 467 Kinsman, S., 561 UROLOGY 54 (6), 1999 Kirkali, Z., 50 Lee, N., 490 Mayo, M.E., 252 Nickel, J.C., 229 Kirkels, W.J., 718 Leé, Y-H..823 McBride, R.B., 875 Nickerson, T., 1120 Kirsh, E.J., 86, 573 Lehmann, K., 539 McCammon, K.A., 509 Niggemann, S., 416 Kitahara, S., 1078 Leibovitch, I., 193 McCullough, D., 853 Noe, H.N., 356 Klee, G.G., 839 Lemack, G.E., 37, 461 McDougal, E., 767 Noll, F., 458 Klee, L.W., 679 Lembo, A., 258 McDougal, W.S., 373 Nomura, Y., 829 Klein, E.A., 130, 366, 617, 884 Lemkin, P.F., 934 McDougall, E.M., 437 Norbut, A.M., 366 Klionsky, D., 135 Leng, W.W., 597 McGuire, E.J., 597 Nordling, J., 278 Klotz, D.H., 1082 Lemer,’S.P. 561 McKenna, P.H., 1097 Noriki, S., 763 Klotz, L., 956 Lessing, J.B., 268 McKinlay, J.B., 1022 Novick, A.C., 215, 617, 994, Klotz, T., 416 Levin, R.M., 183 McNamara, D.E., 625 1091 Klutke, C.G., 1003 Levin, S.S., 183 Megias,J. , 656 Nudell, D.M., 1049 Klutke, J.J., 1003 Levine, M., 240 Meka, C.S.R., 1105 Nyberg, L.M., 229 Kolettis, P.N., 894 Levinson, A.K., 968 Melegos, D.N., 753 Kolligian, M.E., 383 Levitt, S.B., 561 Melman, A., 662 Kolm, P., 509 i a 2453025 Mian, A., 1012 Obek, C., 533, 682 Kolon, T.F., 1097 Li, W., 829 Miayake, H., 6A-36 Oefelein, M.G., 694 Kolski, J.M., 1017 Lianidou, E., 753 Miller, J., 988 Offiah, L., 162 Kolvenbag, G.J.C.M., 194 Libertino, J.A., 1058 Miller, L.J., 567 Oh, W.K., 1064 Konami, T., 44 Lieber, M.M., 335 Miller, M.C., 791 O'Hara, J.F., jr; 130 Konety, B.R., 171, 636 Lilja, H., 753 Miller, P., 278 Ohashi, Y., 313 Koo, J., 744 Lin, D.W., 366 Milliron, A.R., 23 Ohnishi, N., 183 Kotake, T., 313 Lindquist, R., 567 Mimata, H., 829 Okabe, T., 44 Kovar, D.A., 573 Littrup, P.J., 1044 Mingrone, G., 629 Okada, K., 313, 763 Kowalczyk, P., 567 Litwin, M.S., 503 Mira, A., 656 Okada, T., 225 Koyle, M.A., 912 Lopez-Po, P., 952 Mishra, A., 346 Okada, Y., 44 Kozlowski, D., 670 Losa, A., 258 Miwa, Y., 763 Okubo, K., 44, 225 Kratzik, C.,517 Loughlin, K.R., 523, 796 Miyake, H., 562 Olencki, T.E., 617 Krege, S., 458 Low, L.L.M., 363 Molberg, K., 162 Olsen, J.O., 1058 Kreutzer, D.L., 567 Lowe, F.C., 81 Montague, D.K., 352, 384 Olson, P.J., 81 Kreutzer, E.R., 34 Lu, C.-M., 823 Monti, P.R., 152 Olsson, C.A., 490, 1039 Krieger, J.N., 366 Lubeck, D.P., 424, 503 Montie, J.E., 319 O'Malley, K.J., 923 Krill, D., 171 LuecEF:, 739 Moon, T.D., 162 Onik, G.M., 135 Krongrad, A., 949 Lummen, G., 458 Mootha, R.K., 561 Ornstein, D.K., 194 Kubricht, W.S., III, 1035 Lundberg, J.O.N., 264 Mor, Y., 744 Ortega, J.-C., 857 Kumamoto, Y., 335 Lundberg, S., 329 Mori, H., 829 Orth, K., 746 Kumar, A., 295 Lu-Yao, G.L., 301 Moro, U., 923 Osella, G., 612 Kumar, A.B., 135 Morton, R.A., Jr, 869 Osterloh, I.H., 346 Kumar, S., 796 Mottet, N., 467 O'Toole, K.M., 1039 Kundu, S.D., 164 Ma. C.-P.. 377 Moyad, M.A., 319 Otto, T., 458 Kuo, H.-C., 90, 802 Maeda, H., 22 Mroczek-Musulman, E., 744 Oyama, N., 763 Kupelian, P.A., 884 Maekawa, S., Miller, S.C., 714 OzeroE., 30 Kursh, E.D., 617 Munding, M., 1097 Maguire, R.T., 1058 Kusne, S., 366 Mungan, M.U., 50 Main, B., 509 Munoz, D.R., 420 Maisonnette, F., 744 Pacelli, A., 67, 479 Munson, J.L., 730 Malavaud, B., 923 Padley, R.J., 81 Murphy, D.M., 923 Labbie, A., 152 Malice, M.-P., 278 Paick, J.-S., 544 Murphy, G.P., 6A-19 Lablanc, G., 194 Malik, S.N., 62 Palmer, J.S., 162 Murphy, W.M., 62 Labrie, F., 194 Malyszko, B., 490 Palmer, L.S., 34, 561 Mustonen, S., 278 Lagiou, P., 284 Mangold, L.A., 791 Pannek, J., 934 ahaie, M., 607 Manibo, J.F., 742 Panser, L.A., 335 ai, S., 533, 682, 949 Manyak, MJ., 1058 Pantuck, A., 208 _akin, M.M., 308 Manzarbeita, C., 366 Nachmann, M.M., 366 Pantuck, A.J., 162 _akshmanan, Y., 934 Manzetti, A., 258 Nakada, S.Y., 162 Panvichian, R., 746 _amm, D.L., 56 Marberger, M., 18, 73, 517, Nangia, A., 636 Parchment, R.E., 6A-22 an, S.-J., 823 603, 846 Nap, M., 561 Park, C-H., 252 ang, E.K., 234 Marinbakh, A.Y., 744 Naughton, C.K., 744 Partin, A.W., 1, 220, 791, ang, S., 164 Marshall, F.F., 913, 1088 Neal, C.E., 1058 839, 934, 1058 ange, P.H., 252, 6A-1 Marshall, V.R., 834 Negendank, W.G., 118 Pasqualotto, F., 583 -angenstroer, P., 23 Martinez, A.A., 111 Nehra, A., 587 Pasta, D.J., 503 arson, T.R., 67 Masel, J., 1097 Nelson, C., 6A-36 Pathologist Multi Center Masoudi, J.F., 744 Nelson, D.R., 308 Study Group, 467 audone, V.P., 567 Masumori, N., 335 Nelson, J.B., 1064 Paulhac, P., 744 Laufer, M., 745 Mateo, R., 366 Netto, J.M.B., 742, 744 Pearson, J.D., 780 Lechevallier, E., 857 Matos-Ferriera, A., 278 Newhouse, J.H., 490 Pedersen, K., 329 Lecksell, K., 291, 528 Mattson, S., 862 Newman, J., 559 Pels Rijcken, T.H., 1068 Lee, C., 164 Matzkin, H., 430 Newman, J.L., 561 Peretsman, S.J., 548 Lee F., 135; 295 Maxa, L.S., 968 Nezu, F.M., 929 Pérez, L.M., 742, 744 Lee, K.L., 444 May, R., 709 Ng, C.S., 366 Perrotti, M., 208 1132 UROLOGY 54 (6), 1999 Peters, K.M., 450 Rosenbaum, R.R., 34 Shinohara, K., 689 Thuroff, S., 273 Petros, J.A., 923 Rosenblum, M., 6A-1] Shoskes, D.A., 960 Tigrani, V.S.. 689 Petrylak, D.P., 490, 6A-30 Ross, B.D., 1112 Shown, T., 662 Tiguert, R., 1008 Peyrat, L., 467 Rosser, C.J., 853 Shrake, P.D., 968 Tindall, D.J., 839 Piantadosi, S., 1058 Roux, F., 857 Shu, S., 617 lobisu. K.-I.. 313 Pichlmeier, U., 247 Rovner, E.S., 744 Sidransky, D., 561 Tolcher. A.. 6A-36 Pa ickens, C.L., 223 . Roxby, D., 8232 4 SieCgeel , R2 ., 162 ) Townsend, M.F., Ill, =5 61 bdiee een > M.R.> , 132¢ Rubben" , EL; 45SQ8 Silveorr, BRD. L., ~5 61 [richopoulos, :D ., 284 I ienkny, A., 617 ag Rubin, M.A., 1039 Silveri, M., 367 lrichopoulou, A., 284 Pienta, K.J., 319, 746, 1112 Rubinowicz, D., 682 Simard, J., 194 ricoli, J.V., 178 CU 9 9 aS Piille at, MJ., 7744 6 : RRuussso, so, PP.., , 22 8 Siimm mons, G.R., 727 24 riest, J.A., 1008 Pilepich, M.V., 495 Simons, J.W., 401 : . ieckava B14 Se Tsukamoto, | Pinckard, P., 1035 Sinibaldi, V.J., 745 Tu. LM. 982 é o ee u,L -5 JOL Pinnock, C.B., 834 Sadek. S.. 533. 682 Skoog, S.J., 365 I B50 . , 79 Sadek, S., 533, 682 “ee Sens una, B., 5¢ Pinover, W.H., 178 ‘ mr “a ' : 162 Slezak, J., 105, 479 CD vied SY agalowsky, A.1., 162 te: urner, Pinto, K., 356 PS os 167 Smith, J.A., Jr, 976, 6A-8 viens ; = Saint, F., 46 ae Turner, S.L., 124 Pircon, R., 366 < ‘ va Smith, J.J., 11, 730 ; aito, S., 1- as Plante, M.K., 411 Cal ; 1. 940 Smith, M.D., 346 %2 = alomon, L., é Plautz, G.E., 617 < ; Catt M. 65¢ Snodgrass, W.T., 6 ne ‘ anchez-Carbayo, M., 656 707 PLESS Study Group, 662, 670 S 1 + O aoe RE. 719 Snow, P.B., 787 Polansky, M., 982 pn oe "ea BH Soeregi, G., 603 dupa, D., 366 1 + and, F.K., 42 . = > . Polascik, T.J., 382 3 Solliday, M.P., 744 ehling, D.T., 561 5 Wak: 5 Sanda, M.G., 1112 see ae rich. T.. 247 Pollak, M., 1120 taal K. 617 Soloway, M.S., 533, 682, irich, oti Poole. E.C.. 23 sandstrom, K., sé 6A-8 padhyay, J., 359, 964, 1044 Ce aes Santis, W.F., 163 : - - te 14 Porpiglia, F., 612 < ci RA. 252 Soria, F., 656 sami, M., 313 Portis, A., 437 ae a 7 —_ Soygtr, T., 157, 905 zzo, R.G., 994 eons : arda, R., 56 : reas Potter, S.R., 528, 791, 913 C nsec j.-P., 923 Spina, V., 367 ; arramon, J.-P., 92 ae Pound, C.R., 934 ‘ ns 709 ; Spirnak, J.P., 559 : : cs artor, O., Presti, J.C., Jr., 689, 6A-47 . ; ; Sprung, J., 130 <s ia sas Satoh, F., 829 ProstaScint Study Group, 1058 : ; Stadler, W.M., 373 idz 700 Scantlebury, V., 366 Staskin. D.R. 641 aida, F., 7( Puri, K., 1008 Scardino. P.T.. 561. 976 ASR, U-K., aishampayan, U., 6A-22 st Steers, W.D., 12 lerie. E.. 1082 SSccc]hh aafnenre,, WFF..I,J. . , 27186 1262 SteinerG,. , s5 61 = aallaencie n,a y G.,m eres—7 7 3 = Steiner, M.S., 942, 976 ee VAR Raad, I.1., 976 Schellhammer, P., 194 Steinert. B.W.. 450 an Andel, G., 1068 = einert, B.VV., 2H - > 744 Raasch, J., 1044 Schellhammer, P.F., 509 Stier DM. 424 an Arsdalen, K., 744 1 * a : ; es aaa Stier, D.M., 42 i cr 2 Rabbani, F., 28, 208 Schick, E., 808 BS. an Die, C.E., 366 : Stoddard, M.L., 503 oo ae ee eta Racioppi, M., 629 Schiff, P.B., 490 Sinkioe Waa. 446 an Haarst, E.P., 1068 . -_ - oe a 4 > y= Ragni, E., 467 Schlatmann, T.J.M., 1068 Stone. A.. 923 asavada, S.P., 454, 819, 1085 = F one, 5 oe 2)< Rahmanou, F., 744 Schmitz, F.J., 23 Stoner, ].. 171 elasco, J ae 7 . - 3 UL 4 # f Rajfer, J., 919, 960 Schnell, F.J., Jr, 968 ‘ eltri, R.W., 791, 1105 Rajpurkar, A., 145=, 925‘ Schoenberg,5 M., e5 61 StopPpIa cher, R., +11] 7 1] 1] # Streem, S.B., 999 sp nggeivieingdre Ramenofsky, M.L., 1082 Schoeneich, G., 714 Strombere. 1.S., 111 iele, M.K., 444 Pa = . tromberg, j.5., iti Ramon, J., 744 Schubert, J., 433 Strum. S.B.. 324 ijayakumar, S ° - . de an on i > = Rassweiler, J.J., 734 Schulam, P.G., 580, 727 Suda. S.. 652 Villers, A., 923 ne sect aie ae da, - ie Raysor, S.L., 178 Schulman, C.C., 382, 517, 846 Sullivan. M.. 670 Virag, R.. 1073 : = > oe . ee 11Vé , O¢ Raz, S., 454, 819, 1085 Schwartz, B.F., 444 Semsiensh’ ¥. 333 Vivas. C.. 366 : se osnl, , Recker, F., 458 Scott, C.A., 923 277 : a s Sun, G.-H., 377 Reichelt, O., 433 Scriven R, 1082 Susset: 1. 420 A 4: + ) ‘7 - SSetl, . ys Remzi, M., 517, 603, 846 Sedelaar, J.P.M., 97 Suthoclanad ES eriand, KR.S., Ren> froey,e. DD. L., 1+0 1177 Seeggza ll, S.. S., ¢6 2a5 n ; Senki ¥. e7e6e3 aldstreicher, J., 662, 67- 0 Rhandawa, P., Seitz, C., 18, 517, 603 alsh, J.B., 162) Rhodes, T., Sekhon, V.S., 894 Walsh, PJ., 921 Richie, J.P., 6A-15 SelcukiM,. , 157 ae ang, D., 662 Richter, F., 234 Selli, C., 923 Taconis, W.K., 1068 ang, D.Z., 670 Riden, D., 1097 Seo, K.K., 148 Tammela, T.L.J., 278 arren, J., 30] Rigby, O.F., 670 Shaer, A.H., 118 Tanagho, E.A., 1007 atkins-Bruner,D ., 178 Rink, R.C., 724, 923 Shafik, A., 368 Taylor, A., 662 8 Rinker-Schaeffer, C.W., Shahed, A., 960 Fefilli, M.V., 925 ego ages Rittenhouse, H.G., 4, 220, Shalhav, A.L., 366, 437, 590, Tekyi-Mensah, S., 325 Wei, J.T., 607, 945, 994 : Rivosecchi, M., 367 744 Terrell, F., 1017 Weichselbaum, R.R., 700, 875 Roach, M., III, 1049 Shames, D., 323 Terris, M.K., 486, 706 Weidner, W., 988 Roberts, J.L., 924 Shapiro, R., 366 Terzolo, M., 612 Weinberg, V.K., 1049 Robertson, J.L., 709 Sharp, D.S., 869 Tessier, J., 808 Weir, J., 424 Rodriguez, R., 401, 561 Shefi, S., 744 Tewari, A., 945 Weiss, R.E., 162, 208 Rodvold, D.M., 787 Shekarriz, B., 359, 964, Texter, J.H., 1058 Whatley, T., 1035 Roehrborn, C.G., 662 Shekarriz, H., 964 Thomas, A.J., Jr, 894 White, C., 420 Roessler, W., 247 Shimazaki, J., 313 Thoms, W.W., 561 White, R.V., 662 Rollema, H.J., 278 Shinghal, R., 706 Thornby, J.1., 976 Whitmore, K.E., 982 Rosen, R.C., 346 Shingleton, W.B., 1017 Thorning, D.R., 366 Wieland, W.F., 247 UROLOGY 54 (6), 1999 WWWWWiiiiiljleklkdnlisbeuaternmrr,dasg ,,,e Jr.,HSBN.. ..,J,P . J.,9.9, E2 7.11, 20 639450 0 WWWWWruuooinurogd,tdheh trri,uJln. im,g cGt,2ho .8,n4L , D.. HL,J..D,r ,. ,, 41232033056 ,86 839 “YYYYeioesptki,lmo laySin,.a ,Km. CaH.,.R,., J 9.O,0.3 5,66 31 972 9 ZZZZehaeicartcnmlagiarn,na, n , ,YS. .AH1...D,,, . -93H716.967,,3 493630 Williams, C.B., 384 Yoo, J.J., 407 Ziada, A.M., 6A-1 Williams, W.H., 968 Yoon, S.H., 148 Ziaja, E.L., 111 Yamanaka, K., 56 Yortikoglu, K., 50 Winter, D.L., 178 Zimmern, P.E., 37, 461 Winter, K., 495 Yamanishi, T., 65 Yoshida, K.-I., 1078 Zimny, M., 900 Witte, M.N., 869 Yang, T., 164 Yoshida, O., 313 Zincke, H., 105, 479 Wolfert, R.L., 220, 839 Yang, X.J., 528 Yoshiyama, M., 929 Zippe, C.D., 308, 583, 884 Wolfram, R., 603, 846 Yano, M., 1078 Young, C.Y.-F., 839 Zlotta, A., 517 WWoooldm,a n,D .P.I.,, 2Jr6,8 964, 1044 YYYeaaeos;,u daCS.,.,- L.7K,.4 ,6 3 6015 2 YYYuuo,su DnGg=.,SW :.,,M . J.33,74 74 6 A-8 ZZZvluaortrataka,,o wPAs..k,R i.4,,1 ] 3D8.2,, 52834 6 UROLOGY 54 (6), 1999 SUBJECT INDEX Antibiotics, quinolone, intravesical chemotherapy for bladder cancer, 56 (Page numbers in the Supplement to the December issue are Antimicrobial impregnated bladder catheters, catheter- associated bacteriuria, 976 preceded by a “6A-”). Antioxidant activities, rat testis, chronic cocaine administration, 925 Ablatherm device, transrectal high-intensity focused Anuria, infant, bilateral nephrolithotomy for multiple ultrasound, localized prostate carcinoma, 273 cystine stones in infants with, 366 Acid-base balance, urinary intestinal orthotopic reservoir, Apoptosis, paclitaxel-induced, signaling network, in LNCaP ileocecal neobladder compared with ileal neobladder, prostate cancer cell line, 746 629 Azoospermia, idiopathic, CAG repeat length androgen Acid secretion, gastric pouch, physiologic digestive function, receptor gene, 1073 50 5. Adenocarcinoma detection, urinary microsatellite analysis, augmentation Bacille Calmette-Gueérin cystoplasty, 561 alteration of immune profile in interstitial cystitis, exstrophic bladder, 744 cytokine levels in, 450 prostate stage T1 grade 3 bladder cancer therapy, 258 mucinous carcinoma, 141 Bacteriuria pathologic stage T3, recurrence, microvessel density, asymptomatic, children, lack of morbidity, urodynamic 479 studies, 359 Adrenal incidentaloma, follow-up, ultrasonography, 612 catheter-associated, antimicrobial impregnated bladder Adrenal metastasis, contralateral, renal cell carcinoma catheter, 976 nephrectomy, 162 Bcl-2 gene, targeting, to delay androgen-independent solitary metachronous, 162 progression and enhance chemosensitivity in prostate Adrenalectomy, ipsilateral, radical nephrectomy, renal cell cancer using antisense Bcl-2 oligonucleotides, 6A—36 carcinoma (letter), 193 Behcet’s syndrome, left ventricular aneurysm, ruptured renal Age artery pseudoaneurysm, 162 disease recurrence after radical prostatectomy, 533 Beta-(2 methoxyphenoxy)-lactic acid, carboxylate salt, radical prostatectomy complications and short-term excess, guaifenesin abuse, urolithiasis, 23 mortality, 301 Beta-trace protein, glomerular filtration rate (letter), 940 sexual function decline in Japanese men compared with Bicalutamide (Casodex) American men, 335 -induced prostate regression, increased expression of total and transition zone prostate volume and, PSA-based genes encoding insulin-like growth factor binding diagnostic parameters for early prostate cancer, 846 protein, 1120 Alpha-blockade metastatic prostate cancer, rapid disease progression, / 45 benign prostatic hyperplasia, 776 relative potency (letter), 194 neoadjuvant and adjuvant, high-energy transurethral Biochemical control rates, treatment for prostate cancer, microwave thermotherapy, compared with temporary caution in interpreting, follow-up length influences transurethral prostatic bridge-catheter, 73 875 response, benign prostatic hyperplasia, magnetic Biochemical failure resonance imaging, 829 overall survival, radical prostatectomy for localized uroselective, benign prostatic hyperplasia, 773 prostate cancer, 884 Amebiasis, genital, 952 prostate-specific antigen-based, 700 American men, decline in sexual function with age, Bladder compared with Japanese men, 335 augmentation, ventriculoperitoneal shunt infection, 356 Ammonium transport, in intestine exposed to urine, 373 compression, extrinsic, pubic bone spur (images), 919 Analgesia, extracorporeal shock wave lithotripsy evacuation, magnetic stimulation, 368 Medstone STS lithotriptor, 625 microtacks, pelvic laparoscopic surgery, 162 transcutaneous electrical nerve stimulation, 433 mucosal cell abnormalities, symptomatic outcome, Androgen deprivation, prostate cancer, 6A—15 transurethral resection of prostate, 834 bone density loss, 607 neuropathic, ileovesicostomy, advantages and risks, 636 chronic, serum testosterone-based luteinizing hormone- Bladder cancer releasing hormone agonist redosing schedule, 694 adenocarcinoma, exstrophic bladder, 744 testicular (letter), 194 immunolocalization of inducible and constitutive nitric Androgen-independent progression, in prostate cancer oxide synthase, +16 delay, targeting Bcl-2 gene, using antisense Bcl-2 spina bifida patient, 923 oligonucleotides, 6A-—36 Bladder cancer diagnosis Androgen receptor gene, CAG repeat length, idiopathic transitional cell carcinoma, rapid test, 656 azoospermia, 1073 urinary cytology consultation, 62 Androgen suppression, postoperative irradiation efficacy, Bladder cancer prognosis RTOG 85-31 analysis, 495 high-grade T1, angiogenesis, immunoreactivity ol Aneurysm, left ventricular, Behcet’s syndrome with, 162 cathepsin D, collagen type IV, 50 Angiogenesis, high-grade stage T1 primary bladder cancer Bladder cancer risk prognosis, 50 tea consumption, fluid intake and, 823 Angiography, Doppler, contrast-enhanced three-dimensional Bladder cancer treatment power, human prostate, correlation with biopsy bacille Calmette-Guérin, in stage T1 grade 3 cancer, 258 outcome, 97 intravesical chemotherapy, quinolone antibiotics, 56 Anti-androgens, prostate cancer, 6A—15 intravesical pertussis toxin, +58 © 1999, ELsEvIER SCIENCE IN¢ 0090-4295/99/$20.00 ALL RIGHTS RESERVED PIL SOO90-4295(99)00525-7 1135 photodynamic therapy, calphostin C, in vitro evaluation, Cerebral abscess, and Citrobacter diversus urosepsis, in child 573 with antenatal hydronephrosis, 1097 Bladder dysfunction, neurogenic, incontinent Chemotherapy, prostate cancer ileovesicostomy, 1008 adjuvant, trials, urologist role, 6A-47 Bladder inflammation, luminal nitric oxide measurement hormone-refractory, urologist role, 6A—51 using silicon balloon catheter, 264 Ciprofloxacin, intravesical chemotherapy for bladder cancer, Bladder outlet obstruction 56 diagnosis, clinical prostate score, prostate measurement Citrobacter diversus urosepsis and cerebral abscess in child and uroflowmetry, 90 with antenatal hydronephrosis, 1097 in men, pressure-flow parameters, finasteride Cleveland Clinic, experience with penile fracture, 352 improvement of, 278 Cloaca, persistent, prenatal diagnosis, 367 partial, induced contractile dysfunction, sucrose diuresis Cocaine administration, chronic, lipid peroxidation and protection,, 183 antioxidant activities, rate testis, 925 Bladder replacement, gastric segment, acid secretion, 553 Cocktail modulator mixtures, multidrug resistance in renal Blood pressure, terazosin effects, benign prostatic cell carcinoma, 377 hyperplasia, concurrent antihypertensives, 81 Collagen injection Blood transfusion, autologous periurethral, female stress urinary incontinence, 815 percutaneous nephrolithotomy, +44 prostatectomy incontinence, 597 radical retropubic prostatectomy, cardiopulmonary risk, Collagen matrix, acellular, biomaterial for urethral repair, 407 130 Collagen type IV, high-grade stage T1 primary bladder Bone density loss, androgen deprivation, 607 cancer prognosis, 50 Bone marrow magnetic resonance imaging, high-risk Colposuspension, Burch, long-term results, and review of prostate cancer, 118 published reports, 808 Book reviews Computed tomography Atlas of Erectile Dysfunction, An, 942 abdomen and pelvis, prostate cancer staging, 490 Color Atlas of Endourology, 580 three-dimensional reconstruction, renal artery thrombosis, Erectile Dysfunction, 580 559 Glenn’s Urologic Surgery, 5th ed., 942 Continence rates, urodynamic parameters, continent urinary Interstitial Cystitis, 198 reservoirs, comparison of segments, 252 Brachytherapy Continent stoma procedure, laparoscopic-assisted, pediatric, permanent, recurrent prostate cancer salvage treatment, 909 880 Contractile dysfunction, partial bladder outlet obstruction- salvage induced, sucrose diuresis protection, 183 radiorecurrent prostate cancer, 204 Costs, hospital, radical nephrectomy versus nephron-sparing rising PSA, external beam radiation therapy, 201 surgery, renal cell carcinoma, 994 BRCA1-like immunoreactivity of human seminal plasma, Crural venous leakage, surgery, 739 characterization, 753 Cryoablation, prostate cancer, patient-reported Brown, James, catheterization of male ureter: June 9, 1893, complications, 300 188 Cryopreservation, sperm, testicular cancer, 894 Burn scar, squamous cell carcinoma at base of penis, 923 Cryosurgery prostate cancer, improved glandular ablation, 6 to 8 cryoprobes, 135 CAG repeat length, androgen receptor gene, idiopathic renal, 215 azoospermia, 1073 Culdosuspension, transvaginal, technique and results, 819 Calphostin C, bladder cancer photodynamic therapy, in Cyst vitro evaluation, 573 epidermoid, scrotum, extending into true pelvis, 561 Capromab pendetide, indium-111 immunoscintigraphy, prostatic, intraurethral, anterior, clinical features and prostate cancer, 1058 management, 923 testicular, simple, and teratoma, first year of life, 366 Cardiopulmonary risk, preoperative autologous blood Cystine stones, multiple, in infant with anuria, bilateral donation radical retropubic prostatectomy, 130 nephrolithotomy, 366 Casodex. See Bicalutamide Cystocele, paravaginal defect repair, 647 Castration, early, prostatic carcinogenesis in transgenic Cystoplasty, augmentation, adenocarcinoma detection, mice, 1112 urinary microsatellite analysis, 561 Cathepsin D, immunoreactivity, high-grade stage T1 Cystoscopic light test, differentiation of high grade pelvic primary bladder cancer prognosis, 50 organ prolapse, 1084 Catheter Cystoscopy introducer sheath, flexible ureteroscopy, 557 -associated bacteriuria, antimicrobial impregnated bladder Cytokine levels, urinary, interstitial cystitis, intravesical catheters, 976 bacille Calmette-Guérin alteration of immune profile, balloon, silicon, luminal nitric oxide in bladder 450 inflammation using, 264 Cytomegalovirus infection, native ureter, after liver-kidney hydrogel/silver ion-coated, nosocomial urinary tract transplantation, 366 infection rates, intensive care unit patients, 982 intraurethral prostatic bridge, temporary, compared with neoadjuvant and adjuvant alpha-blockade, high- Diet, benign prostatic hyperplasia, 284 energy transurethral microwave thermotherapy, 73 Digestive function, physiologic, gastric pouch acid secretion, Catheterization, male ureter, Dr. James Brown and: June 9, 553 1893, 188 Digital rectal examination. See Rectal examination CD44 adhesion molecules, expression, in nonpapillary renal Diuresis, sucrose, bladder outlet partial obstruction-induced cell carcinoma and normal kidneys, 562 contractile dysfunction protection by, 183 1136 UROLOGY 54 (6), 1999 Docetaxel, pharmacokinetics and pharmacodynamics, Gastric carcinoma, metastasis, ureter, 561] 6A-22 Gastric pouch acid secretion, physiologic digestive function, Doppler angiography, contrast-enhanced three-dimensional 553 power, human prostate, correlation with biopsy Gene therapy outcome, 97 pro-drug, prostate cancer, 1098 urologic applications, 401] Electrolyte balance, urinary intestinal orthotopic reservoir, Genital amebiasis, 952 ileocecal neobladder compared with ileal neobladder, Germ cell tumors 629 nonseminomatous, low-stage, retroperitoneal lymph node Endocrine therapy, stages B2 and C prostate cancer, radical dissection, retroperitoneal recurrences, 548 prostatectomy versus external beam radiation testicular therapy, long-term results of randomized trial for, bilateral, clinical course and histopathologic risk factor 313 assessment, 714 Endopyelotomy clinical stage I, nonseminomatous, laparoscopic outcome, high versus dependent ureteral insertion, 999 retroperitoneal lymph node dissection, 1064 retrograde, active distal ureteral dilation, 7F ureteral “tail” Gleason score 7, small foci, prostate cancer needle biopsy stent, 744 328 Endoscopy, reconstruction of vesicourethral obliteration, Glomerular filtration rate, beta-trace proteins (letter), 940 retropubic prostatectomy, 913 Gonadoblastoma, false-positive pregnancy test, 162 Endothelial growth factor, vascular, plasma levels, metastatic Gore-Tex patch sling, long-term results, 641 prostate cancer, 523 Guaifenesin, abuse, carboxylate salt of beta-(2 Endothelial growth factor receptors, vascular, expression in methoxyphenoxy)-lactic acid excess, urolithiasis, 23 human prostate cancer, 567 Gunshot injuries, renal, 972 Epidermoid cyst, scrotum, extending into true pelvis, 561 Epithelial cells, prostate, vitamin D differential effects, 171 Hematuria Epithelial tumor, Millerian-type, torsed appendix testis, 561 Merkel cell tumor metastatic to bladder, 163 Erectile dysfunction. See also Sildenafil urethral polyp in male infant, 921 after radiation therapy for prostate cancer, sildenafil Hernia, ureterosciatic, laparoscopic repair, 730 citrate (Viagra) treatment, 308 Hormonal therapies oral pharmacotherapy, 392 prostate cancer, 6A—15 psychological factors, DSM-IV diagnosis, sildenafil citrate prostate-specific antigen levels, 325 (letter), 579 Hydrogel/silver ion-coated urinary catheter, nosocomial testing urinary tract infection rates, intensive care unit intracavernous prostaglandin E,, variable response, 539 patients, 982 questionnaires replacing, 719 Hydro-jet dissection, laparoscopic nephrectomy, 964 vacuum constriction devices, 891] Hydrometrocolpos. inadvertent perivaginal placement of Erectile function domain, International Index of Erectile artificial urinary sphincter, 923 Function, diagnostic evaluation, 346 Hydronephrosis, antenatal, Citrobacter diversus urosepsis Ethanol, absolute, transurethral intraprostatic injection and cerebral abscess, 1097 infection, ablation of canine prostate, 411] Hyperechogenicity, renal medullary, of neonate, 365 Ethical considerations in fetal urology, 1093 Hypospadias Eulexin. See Flutamide complications, repair, previously utilized urethra | pI late, 724 Fascial sling, erosion into urethra, 923 repair, tubularized incised plate, 6 Females. See women Fetal urology. See also Pediatric urology Ileal neobladder diamniotic twin gestation discordant for renal dysplasia -enteric fistula, conservative management, 366 and oligohydramnios, 1097 orthotopic, voiding function, in women, 44 ethical considerations, 1093 Ileovesicostomy, neuropathic bladder prenatal karyotype and ultrasound discordance in advantages and risks, 636 intersex, 1097 incontinent, 1008 1 Fibrosis, penile, penile implant, multiple incisions, minimal Immunoreactivity, BRCA1-likiek , of human seminal plasma, scar tissue excision, 145 characterization, 75 3 Finasteride Immunoscintigraphy, 111-In capromab pendetide, prostate bother and other health-related quality of life aspects, cancer, 1058 benign prostatic hyperplasia, 670 Immunotherapy, adoptive, T-cell, metastatic renal cell improvement in pressure-flow parameters in men, 278 carcinoma, 617 long-term changes in symptoms and flow rate, versus Incontinence, urinary. See also Surgery, anti-incontinence placebo, 662 intractable, children Fistula, ileal neobladder-enteric, conservative management, myofascial wrap (letter), 383 366 prostatectomy, collagen injection, 597 FK506, toxic levels, stuttering priapism in liver transplant stress patient with, 366 female, paravaginal defect repair, 647 Flank incision, renal donors, morbidity, 796 female, periurethral collagen injection, 815 Fluid consumption, tea consumption, bladder cancer risk, persistent, quality of life after suspension procedures, 823 247 18-Fluoro-deoxyglucose, positron emission tomography, pubovaginal sling, ideourodynamic results, 802 clinical staging of testicular cancer, 900 urge Flutamide (Eulexin), relative potency (letter), 194 oxybutynin once-daily formulation, evaluation, +20 UROLOGY 54 (6), 1999 1137 Indium-111-capromab pendetide immunoscintigraphy, Laser ablation of prostate, versus transurethral resection of prostate cancer, 1058 prostate, benign prostatic hyperplasia, 1017 Infection Length-of-stay cytomegalovirus, native ureter, after liver-kidney hospital, radical nephrectomy versus nephron-sparing transplantation, 366 surgery, renal cell carcinoma, 994 nosocomial, rates, urinary tract, intensive care unit Leydig cell tumor, testis, organ-sparing bilateral surgery, 744 patients, hydrogel/silver ion-coated catheter, 982 Lipid peroxidation, rat testis, chronic cocaine upper urinary tract, advanced, percutaneous administration, 925 nephrostomy, 234 Lithotripsy, extracorporeal shock wave ventriculoperitoneal shunt, bladder augmentation, 356 analgesia Infertility, testicular cancer, sperm cryopreservation, 894 Medstone STS lithotriptor, 625 Inflammation transcutaneous electrical nerve stimulation, 433 bladder, measurement of luminal nitric oxide using rate of shock delivery, stone fragmentation, 430 silicon balloon catheter, 264 Liver-kidney transplantation, cytomegalovirus infection of high-grade, prostate cancer, prognostic factor for native ureter, 366 biochemical recurrence, radical prostatectomy, 467 Liver transplant patient, stuttering priapism, toxic levels of Infrarenal vena caval tumor thrombus, renal cell carcinoma, FK506, 366 561 Lower urinary tract symptoms, phytotherapeutic agents, Insulin-like growth factor 1, prostate-specific antigen ratio, analysis and awareness of use, 86 prostate cancer detection, 603 Luteinizing hormone-releasing hormone agonist, Insulin-like growth factor binding protein, genes encoding, testosterone-based, plasma, redosing schedule, increased expression, bicalutamide-induced prostate chronic androgen ablation, 694 regression, 1120 Luteinizing hormone-releasing hormone analogue, radical Insulin-like growth factor binding protein-2, high risk prostatectomy failure after, tumor cell proliferation, prostate cancer development, racial differences, 178 329 Intensive care unit patients, nosocomial urinary tract Lymphoma infection, hydrogel/silver ion-coated catheters, 982 non-Hodgkin’s. See Non-Hodgkin’s lymphoma International Index of Erectile Function, diagnostic penile, primary, diagnostic difficulties and management evaluation of erectile function domain, 346 options, 366 Intersex, ultrasound discordance, prenatal karyotype and, 1097 Intestinal orthotopic reservoir. See Urinary intestinal Magnetic resonance imaging orthotopic reservoir alpha-blocker response in benign prostatic hyperplasia, Intestine, exposed to urine, ammonium transport, 373 829 Intraepithelial neoplasia, prostatic. See Prostatic bone marrow, high-risk prostate cancer, 118 intraepithelial neoplasia dynamic, grading pelvic prolapse and pelvic floor Intraurethral prostatic bridge-catheter, temporary, compared relaxation, 454 with neoadjuvant and adjuvant alpha-blockade, high- voiding dysfunction, in children, 157 energy transurethral microwave thermotherapy, 73 Magnetic stimulation Inventory-6 Questionnaire, urodynamic findings, evacuation of neuropathic rectum and urinary bladder, predictability, +61 368 functional continuous, urethral closure, 652 Japanese men, decline in sexual function with age, compared Men with American men, 335 Japanese, decline in sexual function with age, compared with American men, 335 pressure-flow parameters, finasteride improvement of, 278 Kallikrein 2, human glandular, prostate cancer detection, Merkel cell tumor, metastatic to bladder, hematuria, 163 839 Microtacks, bladder, laparoscopic pelvic surgery, 162 Karyotype, prenatal, and ultrasound discordance in intersex, Microvessel density, pathologic stage T3 prostate 1097 adenocarcinoma recurrence, 479 Kidney Micturition, changes, spinal cord injury, 929 normal, CD44 adhesion molecules expression, 562 Monti procedure, as continent catheterizable stoma, 152 polycystic disease, autosomal recessive, prenatally Mortality, radical prostatectomy, short-term, age and diagnosed, initial postnatal management, 1097 surgical approach, 301 Kidney transplant recipients Mucinous carcinoma, prostate, 141 See Renal transplant recipients Mucosal cell abnormalities, bladder, symptomatic outcome, transurethral resection of prostate, 834 Lambert-Eaton myasthenic syndrome, transitional cell Mullerian-type epithelial tumor, torsed appendix testis, 561 carcinoma, 162 Myasthenic syndrome, Lambert-Eaton, transitional cell Laparoscopic surgery carcinoma, 162 continent stoma procedure, pediatric, 909 Myofascial wrap, intractable urinary incontinence, in nephrectomy children (letter), 383 Hydro-Jet dissection, 964 xanthogranulomatous pyelonephritis, 437 open access, radially dilating trocar sleeve, 727 Narcotic-seeking behavior, urolithiasis, 744 pelvic, bladder microtacks, 162 National Institutes of Health, First International Prostatitis retroperitoneal lymph node dissection for clinical stage | Collaborative Network, consensus report, on nonseminomatous germ cell testicular tumors, 1064 research guidelines for chronic prostatitis, 229 ureterosciatic hernia, 730 Needle biopsy. See Prostate biopsy 1138 UROLOGY 54 (6), 1999

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users